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Bone marrow (BM) stromal cells are ascribed two key functions, 1) stem
cells for non-hematopoietic tissues (MSC) and 2) as components of the
hematopoietic stem cell niche. Current approaches studying the stromal cell
system in the mouse are complicated by the low yield of clonogenic progenitors
(CFU-F). Given the perivascular location of MSC in BM, we developed an
alternative methodology to isolate MSC from mBM. An intact ‘plug’ of bone
marrow is expelled from bones and enzymatically disaggregated to yield a single
cell suspension. The recovery of CFU-F (1917.95+199) reproducibly exceeds
that obtained using the standard BM flushing technique (14.32+1.9) by at least 2
orders of magnitude (P<0.001; N = 8) with an accompanying 196-fold enrichment
of CFU-F frequency.
Purified BM stromal and vascular endothelial cell populations are readily
obtained by FACS. A detailed immunophenotypic analysis of lineage depleted
BM identified PDGFRαβPOS stromal cell subpopulations distinguished by their
expression of CD105. Both subpopulations retained their original phenotype of
CD105 expression in culture and demonstrate MSC properties of multi-lineage
differentiation and the ability to transfer the hematopoietic microenvironment in
vivo. To determine the capacity of either subpopulation to support long-term
multi-lineage reconstituting HSCs, we fractionated BM stromal cells into either
the LinNEGPDGFRαβPOSCD105POS and LINNEGPDGFRαβPOSCD105LOW/populations and tested their capacity to support LT-HSC by co-culturing each
population with either 1 or 10 HSCs for 10 days. Following the 10 day co-culture
period, both populations supported transplantable HSCs from 10 cells/well co-

cultures demonstrating high levels of donor repopulation with an average of
65+23.6% chimerism from CD105POS co-cultures and 49.3+19.5% chimerism
from the CD105NEG co-cultures. However, we observed a significant difference
when mice were transplanted with the progeny of a single co-cultured HSC. In
these experiments, CD105POS co-cultures (100%) demonstrated long-term multilineage reconstitution, while only 4 of 8 mice (50%) from CD105NEG -single HSC
co-cultures demonstrated long-term reconstitution, suggesting a more limited
expansion of functional stem cells. Taken together, these results demonstrate
that the PDGFRαβCD105POS stromal cell subpopulation is distinguished by a
unique capacity to support the expansion of long-term reconstituting HSCs in
vitro.
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CHAPTER 1:
OVERVIEW AND AIMS

1

1-1: THE HEMATOPOIETIC SYSTEM: OVERVIEW

The hematopoietic system is one of the most highly regenerative systems in
mammals with approximately 1011 mature blood cells being replaced each day in
humans [1]. Along with the inception of BM transplantations nearly 40 years ago [1],
a significant amount of progress has been gained from a growing knowledge
regarding the identification, localization and regulation of hematopoietic stem cells
(HSC) and has, as a consequence, ushered in the development of cellular and
molecular therapies for hematological disease such as leukemia. Key observations
of individuals who died of hematopoietic failure following the fall out from radiation
exposure after the atomic bomb explosions in Hiroshima and Nagasaki in 1945,
became a paradigm to study the hematopoietic system in humans and mice.
Seminal experiments in hematopoietic cell transplantation, began following the
observation that morbidity due to radiation poisoning could be prevented in mice by
protecting the spleen with a lead shield [2, 3] and subsequently by transplanting
spleen or bone marrow cells into irradiated host [4, 5].
Currently, bone marrow transplantation remains a widely used treatment
modality for many human genetic disorders, bone marrow failure and cancers [6, 7].
Traditionally whole bone marrow was used as the primary source of hematopoietic
stem/progenitors (HSPCs) for donor derived blood reconstitution in patients.
Additionally, the cytokine granulocyte colony-stimulating factor (G-CSF) is given
either to patients or donors to mobilize HSPCs into circulation from which the cells
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can then be recovered by aphaeresis and transplanted into patients. Although
successful for many patients, bone marrow transplantation from these adult sources
comes with both limitations and caveats. One such limitation is that adult cell
sources of HSPCs from either BM or mobilized peripheral blood require a high
degree of matching of the Histocompatibility complex leukocyte antigen (HLA)
between donor and recipient to reduce the risk of graft versus host disease [8]. As a
consequence, many patients are left without the option of an appropriately matched
donor.
More recently, umbilical cord blood (UCB) units are becoming an increasingly
used source of HSPCs for cellular therapy. In 1988 Dr. Elaine Gluckman and
colleagues [9] performed the first successful transplantation using a cryo-preserved
UCB unit. Since the first reported UCB transplant, many patients have been
successfully treated with cryo-preserved UCB units for a variety of malignant and
non-malignant hematological disorders [10]. UCB transplantations do not require the
same stringent level of HLA matching as adult cell sources. However, a significant
limitation associated with the use of UCB is the low number of HSPCs per UCB unit
which results in delayed engraftment rate for neutrophils and platelets and a
markedly protracted rate of lymphoid reconstitution [11]. Currently, due to the
reduced HSPC number, UCB units are generally only considered sufficient for
transplantation of children and progress in the application of CB in the adult setting
has been significantly hampered by delayed engraftment kinetics [12, 13]. Therefore,
it is the interest of many labs to overcome the limitations hampering progress in
many adult stem cell fields encompassed in the rarity of the resident adult stem cell
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populations and the largely inability to maintain and/or expand functional stem cells
ex vivo. Consequently, there remains a pressing clinical need to develop improved
strategies for ex vivo propagation of functional hematopoietic stem cells in order to
be able to fully realize the therapeutic potential of UCB. Like many adult tissue stem
cells, HSCs are localized to and regulated by extrinsic cues from highly specialized
‘microenvironments’ referred to as stem cell ‘niches’ [14, 15]. Evidence from many
model organisms suggests that the local microenvironment is key in regulating stem
cell behavior such as self-renewal, proliferation and differentiation [14, 15]. Recent
progress has seen the concept of the hematopoietic niche, first proposed by Ray
Schofield, reduced to a discrete cellular entity within the bone marrow [16]. Current
data suggest that hematopoietic stem cells (HSC) exist both in association with
osteoblasts at the endosteal surface of bone (Osteoblastic niche) [17-19] and also
in contiguity with the bone marrow vasculature and perivascular stromal cells
(Vascular niche) [20-21]. Additionally, recent data suggests that the perivascular
cells situated around sinusoidal endothelial cells (adventitial reticular cells) not only
comprise a critical cellular component of the vascular niche, but also serve as a
resident population of stromal stem/progenitor cells, also known as ‘skeletal’ and
‘mesenchymal’ stem cells (MSCs) [22-25].
These findings bring together the long standing idea that not only do two
distinct lineages of adult stem cell populations exist within the same tissue, the adult
BM; but they are also intimately associated with one another such that one
population, the stromal stem/progenitor cells, is beginning to emerge as a key
cellular constituent of the hematopoietic microenvironment with a direct role in

4

governing HSC behavior (26). In light of these findings, the mouse model provides
an excellent experimental system to further identify and characterize the molecules
governing the extrinsic regulation of HSCs with the prospect of being able to use
these molecules found within the in vivo microenvironment in order to develop
improved strategies for the ex vivo expansion of HSCs. When considering
addressing this very interesting hypothesis, one must also bear in mind the difficulty
found in studying two rare adult stem cell populations simultaneously. Although the
cell surface phenotype for the purification of murine HSCs has been well defined
[20], cell surface markers allowing for the isolation of purified populations of
mesenchymal stromal stem/progenitor cells from mouse bone marrow is still greatly
lacking [27]. Unfortunately much of what is known in the mouse regarding the
stromal cell compartment is largely based on retrospective analysis of a
heterogeneous population of cultured bone marrow stromal cells (BMSCs) and as
such there is little reproduced data suggesting the identity and location of MSCs in
vivo. Furthermore, technical limitations and the lack of adequate isolation strategies
for working with bone marrow tissue, in addition to the large percentage of
hematopoietic cells comprising bone marrow cellularity have hampered progress in
using the mouse model.
A major outstanding question in the field of mouse MSC biology has been the
identification and localization of the cells responsible for establishing the
hematopoietic microenvironment in vivo and whether or not the cells studied in
laboratories actually have identical counterparts in vivo. In the human BM, the in vivo
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location and the ability to isolate MSCs has recently been described [22, 27],
however in the mouse system there remains much more confusion.
This thesis has been centered on addressing some of these difficulties and
has gained significant scientific understanding of the intricacies involved in both
MSC and HSC biology. The following chapters (1) describe a robust and
reproducible approach to both identify and isolate cellular components of the
vascular niche [28], (2) provide evidence of distinct stromal stem/progenitor
populations that exist in vivo within the BM and exhibit transcriptional programs that
suggest different physiological roles, and (3) functional data supporting their role as
hematopoietic niche cellular elements.

6

1-2: AIMS

The overall objective of this dissertation is to investigate the properties of
defined subpopulations of mouse bone marrow stromal cells. This study is aimed at
understanding the biology of the bone marrow vascular/perivascular niche and in
elucidating the role of bone marrow derived stromal stem/progenitor cells in
regulating hematopoietic stem cell (HSC) behavior. The specific goals are to
prospectively isolate candidate populations by means of their distinct cell surface
immunophenotype, to investigate the multilineage differentiation potential of each
stromal cell subpopulation and to measure their ability to support the maintenance of
long-term repopulating hematopoietic stem cells (HSCs) in vitro. Accordingly, a
combination of in vitro and in vivo functional assays were utilized to first evaluate the
stem cell properties of distinct stromal cell populations. Additionally, co-culture and
in vivo long-term blood reconstitution assays were employed to investigate the ability
of the bone morrow stromal progenitor populations to support and/or expand mouse
LSKCD48-CD150+ (LSKSLAM) HSCs. Given recent reports demonstrating that the
vascular niche comprises both sinusoidal endothelial cells and the subendothelial
perivascular cells surrounding the sinusoidal wall [20, 25], this co-culture system
therefore serves as an experimental platform from which to identify novel molecules,
associated with the vascular niche, involved in regulating the survival and
proliferation of functional hematopoietic stem cells. Furthermore, the knowledge
gained from these studies will inform the development of more effective approaches
to recapitulate hematopoietic vascular niche function ex vivo resulting in improved
7

methodologies for the cultivation and expansion of HSCs for therapeutic benefit.
To begin addressing these objectives, it was necessary to first develop a
reproducible methodology that would allow the identification of a specific
immunophenotype for the prospective isolation of subpopulations of bone marrow
stromal

stem/progenitor

cells

(MSCs).

Current

evidence

from

numerous

investigators has demonstrated that MSC occupy a perivascular location within a
number of tissues, including the bone marrow [22, 23, 26,115, 116]. Therefore, we
postulated that preservation of the vasculature would be critical to maximizing the
yield MSC physically situated along the abluminal surface of blood vessels.
In the Chapter 3 of this thesis, I describe a methodology I developed based
on a step-wise enzymatic disaggregation of bone marrow tissue, which led to
significant findings of a complex cellular organization contained within the bone
marrow stromal compartment. These initial results led us to hypothesize that the
adult mouse bone marrow contains phenotypically distinct populations of
MSC, which contribute to the maintenance of HSCs associated with the BM
stem

cell

niches

and

are

prospectively

isolatable

by

distinct

immunophenotypes.
In Chapter 4, I investigate the multipotency of phenotypically defined
candidate stromal stem/progenitor populations. I demonstrate, for the first time, that
the cells commonly referred to in the literature as ‘mesenchymal stem cells’ are in
fact derive from distinct, phenotypically defined subpopulations of stromal cells in
mouse bone marrow. The canonical MSC properties (i.e. differentiation to bone,
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adipose and cartilage tissue) of these stromal cell subpopulations were analyzed by
both in vitro and in vivo assays. Furthermore, transcriptional profiling was used to
gain insight into their biological roles in vivo and these data suggest that each
population is enriched in a small set of genes governing specific biological functions.
In Chapter 5, I determine the ability of each population to recapitulate the
functional properties of the hematopoietic microenvironment in vitro by their
capacity, using co-culture assays, to maintain and/or expand long-term repopulating
mouse HSCs. For these studies a CD45.1/CD45.2 congenic transplant model was
utilized to investigate the potential of co-cultured mouse HSCs to provide long-term
multi-lineage repopulation in lethally irradiated host. I began these studies by first
utilizing the FACS-based methodology described by Kiel, et al. [20] to isolate HSC
from mouse bone marrow and validating their potency in the congenic transplant
model. Using this rigorous, well-validated transplant model, a quantitative
assessment was conducted to determine the capacity of different stromal cell
subpopulations to support the maintenance and/or numerical expansion of
competitive long-term repopulating HSCs.
The studies proposed herein are unique in several important respects. First,
this project for the first time demonstrates that the cells commonly referred to in the
literature as ‘mesenchymal stem cells’ in fact derive from distinct populations of
stromal cells within mouse BM. Secondly, these studies demonstrate that the
hematopoietic supportive capacity of marrow stromal cells resides in discrete
subpopulations that can be prospectively isolated by phenotype and contain the
functional attributes associated with MSC. These data consequently provide
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important additional insights into the ongoing debate, demonstrating that marrow
stromal cells (MSC) with HSC-supportive functions and mesenchymal stem cells
(MSC) are represented within distinct populations of bone marrow stromal cells.
Furthermore, the identification of unique stromal cell subpopulations with enhanced
HSC maintenance potential in vitro provide the basis for future studies directed at
defining the molecular mechanisms responsible for maintaining hematopoietic stem
cell function during ex vivo expansion protocols.
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CHAPTER 2: INTRODUCTION
HEMATOPOIETIC STEM CELLS (HSC) : ARCHETYPAL
ADULT STEM CELLS
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2-1: DISCOVERY OF HEMATOPOIETIC STEM CELLS

Stem cells are classically defined by three principal characteristics; the ability
to self-renew, extensive proliferative potential and the ability to differentiate into
multiple lineages providing a paradigm for tissue formation and maintenance during
turnover (Figure 2-1) [1]. The hematopoietic system continues to be one of the most
well characterized systems used in studying mammalian adult stem cells [6].
Importantly, hematopoietic stem cells are able to undergo self-renewal for the life of
an organism and subsequently provide progenitor cells responsible for replenishing
the entire hematopoietic system [29]. Pioneering work by Till and McCulloch in the
early 1960’s led to the identification of a subset of cells within the bone marrow
(BM), which upon transplantation into lethally irradiated recipients, contained
properties of differentiation, multi-potentiality and self-renewal by forming
macroscopic colonies in the spleen of recipient animals, from which they coined the
term colony forming unit-spleen (CFU-S) [30]. Originally thought to be hematopoietic
stem cells, the colonies that formed in the spleen were initiated by progenitor cells
and were comprised largely of cells of the myeloid lineage such as erythrocytes,
granulocytes and megakaryocytes. However, subsequent work by these authors
later identified additional colonies comprised of cells from the lymphoid lineage [31].
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Figure 2-1: Principles of Stem Cell Biology. Stem cells are largely quiescent cells
in vivo but can be induced, during times of stress, injury or during maintenance of
tissue homeostasis, to undergo self-renewal generating more stem cells in order to
maintain the stem cell pool and/or to proliferate generating progenitor cells which
then become mature cell types of the resident tissue.
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Additionally, a subset of these colony-forming cells could reform multi-potent CFU-S
in the spleens when transplanted into secondary recipients [32]. These pioneering
experiments led Till and McCulloch to propose the idea that some of the cells
responsible for forming colonies of multiple hematopoietic lineages were
hematopoietic stem cells, owing to the ability to undergo self-renewal and multipotential differentiation [3]. However, although the cells responsible for forming the
colonies in the spleen were of clonal origin [33], they were not derived from
hematopoietic stem cells as initially thought. It was later demonstrated by work from
Norman Iscove and colleagues in the 1980’s that these early CFU-S cells were
instead derived from oligopotent progenitors [34].
While these findings were instrumental in developing the concept of a
hematopoietic stem cell that generates all mature blood cell types, it was not until
the late 1980’s and 1990’s that populations could be isolated which were
demonstrated to be enriched in HSCs. Furthermore, tools from both mouse genetics
and molecular biology became available for researches to develop functional assays
to quantitatively measure HSCs within distinct phenotypically defined populations
[35]. Work from Dr. Irving Weissman’s lab has led the field in search for cell-surface
markers that allowed for the prospective isolation of populations of hematopoietic
cells enriched in functional HSCs. As such, the work by his group and others have
led to the development of a distinct immuno-phenotype for isolating HSCs in addition
to more lineage restricted progenitor populations [20, 36-38]. It is now widely
accepted that HSCs are contained within a rare population of cell within the adult
bone marrow that are negative for mature hematopoietic markers (both of myeloid
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and lymphoid lineages) (Lin-), but express both Sca-1 (stem cell antigen-1) [36] and
c-kit [39], most commonly referred to in the literature as LSK.
Of equal importance to the ability to isolate enriched populations of HSCs was
the development of functional assays to measure the frequency of HSCs within a
defined population. Boyse and colleagues [40] were instrumental in developing
congenic mouse strains, which would overcome the barrier of immune rejection. By
generating mouse strains that differed only in one allele for the leukocyte common
antigen Ly5/CD45 that is expressed on the cell surface of all hematopoietic cells, it
now became possible with the use of specific monoclonal antibodies to distinguish
the strain of hematopoietic cells derived from the host from that of the donor cells
under in vivo transplantation assays [3]. These assays are now regarded as the
gold standard for assessing HSC function and are commonly used by all labs
interested in addressing fundamental questions in hematopoietic stem cell biology.
More recently with the development of these powerful tools, researchers have been
able to isolate single HSCs which upon transplantation into a lethally irradiated host
can reconstitute the entire blood system thereby definitively demonstrating the
enormous regenerative potential of HSCs. Work from Sean Morrison’s lab has led to
an immunophenotype using the SLAM family molecules, CD48 and CD150, that has
led to the highest level of enrichment of HSCs to date, whereby 1 of every 2 cells
within the LSKCD48-CD150+ population were able to provide long-term multilineage reconstitution of the entire hematopoietic system [20].
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2-2: HEMATOPOIETIC HIERARCHY

Because HSCs are now routinely isolated and are defined by rigorous longterm reconstitution transplantation assays, significant progress has been made in
not only characterizing HSCs but also in establishing a model for the differentiation
of HSCs into multiple lineages. The hematopoietic system is structured such that the
rare multipotent, self-renewing hematopoietic stem cells (HSCs) are located at the
apex of a three-tiered hierarchy (Figure 2-2) [1, 41]. According to this model, HSCs
give rise to daughter cells, some of which will remain as stem cells while others will
undergo successive progression of differentiation pathways into individual blood
lineages [42]. Long-term blood reconstituting HSCs (LT-HSCs) are able to selfrenew for the life of the organism and also give rise to short-term reconstituting
HSCs (ST-HSCs), which are able to maintain self-renewing properties for
approximately 8 weeks upon transplantation into lethally irradiated recipients [43].
Although ST-HSCs have a limited self-renewal capacity, they have extensive
proliferative potential and are able to serve as a supply source for various lineage
restricted progenitor populations [38]. The IL-17 receptor positive population gives
rise to the common lymphoid progenitors (CLP) producing mature cells committed to
lymphoid fates. B cells, T cells, natural killer (NK) cells and dendritic cells are all
descendents of the CLP progenitor population. The common myeloid progenitor
(CMP) population gives rise to lineage restricted progenitor cells of both the myeloid
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Figure 2-2: Schematic Illustration of the Hematopoietic Developmental
Hierarchy. Self-renewing hematopoietic stem cells reside at the top of a tiered
hierarchy giving rise to multipotent progenitor daughter cells. The multipotent
progenitor cells then give rise to oligo-potent progenitors of either the common
myeloid progenitors (CMP) or common lymphoid progenitors. These oligo-potent
progenitors give rise to a number of lineage restricted intermediate progenitors
which in turn differentiate into the mature effector cells of the hematopoietic
system. (Image generated by Nathalie Brouard, PhD)
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and erythroid lineages. Mature granulocyte and macrophage effector cells are
derived from the granulocyte-macrophage progenitor (GMP) population and mature
megakaryocytes and erythroid cells are generated from the megakaryocyte-erythroid
progenitor (MEP) fraction of lineage restricted progenitor cells [3].
The hierarchical organization of hematopoiesis is long established and well
validated and as a consequence, is often cited as a paradigm for the organization of
stem and progenitors in other constitutively renewing tissues. Within the defined
layers of the hierarchy, the entire hematopoietic system is maintained in a tightly
coordinated manner in which self-renewal versus differentiation programs are
balanced based on the prevailing need of the organism (i.e. under normal steady
state homeostasis or under stress conditions such as occur during infection) without
depleting the critical source of HSCs. There are several well-defined intrinsic
regulators, such as lineage specific transcription factors, that play critical roles in
maintaining the organizational structure of hematopoiesis. However, this balanced
effort is also coordinated by external regulation from distinct micro-environmental
cues, which form critical cellular and extra-cellular components in regulating selfrenewal in addition to lineage specific differentiation pathways [44].
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2-3: ONTOGENY OF HEMATOPOIESIS

Ontogeny of the hematopoietic system is established in two waves throughout
embryo development. Interestingly, HSC development is marked by temporally
regulated changes in anatomical location [45, 46], whereby at each stage HSCs are
exposed to qualitatively different microenvironments endowing specific functions
(Figure 2-3). The mammalian yolk sac is the first site for the emergence of
hematopoiesis, termed primitive hematopoiesis. Here the primary focus is placed on
the generation of erythrocytes to facilitate tissue oxygenation of the rapidly growing
mouse embryo at 7-7.5 dpc [41, 47]. Experimental evidence from Goldie et al.
demonstrated that at a clonal level, a population of specialized endothelial cells
isolated from mouse E8.25 yolk sack were able to generate hematopoietic
progenitor cells [48].
Following the formation of primitive hematopoiesis within the yolk sac, Godin
and colleagues defined the para-aortic splanchnopleur region as the site of
emergence of definitive pluripotent HSCs in mice at 10.5 dpc, [49, 50]. The paraaortic splanchnopleur region further differentiates into the aorta-gonad-mesonephros
region (AGM). Some of the most convincing evidence, supporting the role of the
AMG as the site of emergence of definitive HSCs, was demonstrated by in vivo longterm multi-lineage repopulation provided by intra-embryonic hematopoietic
precursors in lethally irradiated adult recipients [51]. These precursors were able to
give rise to lymphoid and myeloid lineages eight months after transplantation. More
recently, strong experimental evidence has demonstrated that specialized embryonic
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endothelial cells within the AGM, termed hemogenic endothelium, actually serve as
the source for de novo generation of definitive hematopoiesis [52].
Following the emergence of definitive hematopoiesis in the AGM, the fetal
liver becomes the primary site of hematopoiesis at E11.0 dpc. From E11.0 to E15.5,
HSCs in the fetal liver are actively in the cell cycle and undergo rapid expansion
followed by a decline prior to colonizing other hematopoietic organs such as the
spleen and bone marrow where HSCs are found to be largely quiescent [38].
Studies by Christensen et al., demonstrated that long-term repopulating HSCs are
found in circulation throughout fetal development and begin to colonize the fetal
bone marrow at E17.5 after the onset of bone and vasculature development [53].
Throughout murine adult life the bone marrow remains the primary site of
hematopoiesis during steady state conditions, however 100-400 LT-HSCs may be
found in circulation at any one time [54].
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Figure 2-3: Hematopoietic Ontogeny in the mouse. Hematopoietic stem cells first
arise from specific endothelial cells within the AMG region of the developing embryo
at around 9 DPC. Following the generation of definitive hematopoiesis in the AGM,
HSCs are know to migrate to fetal liver were they undergo a massive expansion in
vivo. Prior to birth and following the process of endochondral ossification of long
bones, hematopoiesis moves to the bone marrow where it is to remain under normal
homeostatic conditions. (Image generated by Nathalie Brouard, PhD)
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2-4: THE HEMATOPOIETIC MICROENVIRONMENT

The hematopoietic microenvironment (HM) is classically thought of as a
mileau of cells (hematopoietic and non-hematopoietic stroma), extra-cellular matrix
proteins and growth factors associated with the ECM (Figure 2-4) [55, 56]. The term
stroma is derived from Greek and essentially refers to the physical entity (bed) upon
which somethings lays. In hematopoiesis, the stroma is considered the substrate or
scaffold unpon which hematopoiesis occurs [85]. The progressive identification of
the hematopoietic microenvironment dates to the early 1960s, where initial studies
noted that in lethally irradiated animals that were reconstituted by transfusion with
BM cells, hematopoietic colonies develop only in the BM and spleen [30].
Furthermore when high doses of radiation were given to destroy the stromal
elements of the BM a resulting permanent state of aplasia followed. And hence, a
sequential regeneration of the marrow stromal cells preceded resumption of
hematopoiesis in the bone marrow [57, 58]. However, some of the most convincing
evidence of the role of the microenvironment came from using genetic mouse
models. Mice with mutant recessive alleles in either the Sl/Sld and W/WV loci gave
rise to macrocytic anemia. Interestingly, bone marrow cells from Sl/Sld mice were
able to rescue lethally irradiated wild-type littermates and W/WV mice [59]. These
studies conclude that the defect in Sl/Sld mice was expressed phenotypically as a
failure of the HM. It is now understood that the W locus encodes the c-Kit prooncogene and the Steel locus encodes for its ligand, stem cell factor.
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Later studies by Dexter and colleagues in the mid 1970s resulted in the
establishment of a culture system that maintained primitive mouse hematopoietic
progenitor cells in vitro [60, 61]. From these observations the authors conclude that
the maintenance of hematopoiesis in vitro was dependent on an adherent layer of
marrow derived cells whose composition reflected the phenotypic diversity of the
stromal elements in the BM in vivo [61]. The historical importance of these findings
allowed Ray Schofield to formulate his niche hypothesis in which he states that,
“the stem cell is seen in association with other cells which determine its
behavior. It becomes essentially a fixed tissue cell. Its maturation is
prevented and as a result its continued proliferation as a stem cell is
assured. Its progeny, unless they can occupy a similar stem cell ‘niche’,
acquire a high probability of differentiation” [16].
Since the inception of the regulatory role of the BM stroma governing
hematopoietic stem and progenitor cell behavior, there has been an increasing
interest to identify cells and molecules responsible for orchestrating HSC
quiescence, self-renewal, differentiation and proliferation. Two primary approaches
have been applied to the discovery of such regulatory molecules; one approach has
been through the use of mouse genetics and the other has been to use in vitro
assays of either long-term marrow cultures or suspension cultures as an
experimental tool to identify both cellular and molecular constituents that control
HSC behavior. Several factors have been identified to have a genetic requirement
and include stem cell factor (SCF), Thrombopoeitin (TPO), CXCL12 (SDF-1),
osteopontin, and angiopoietin (Ang-1) [15, 62]. As such, most investigators in search
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of additional regulatory mechanisms controlling HSC expansion in vitro have used
several combinations of these factors in soluble form. However although essential in
vivo, combinations of these molecules are unable to support either the maintenance
or expansion of purified HSCs in vitro. Additional efforts have traditionally been to
use adherent stromal cells from hematopoietic tissues as a means to identify cells
with the ability to support and expand transplantable HSCs in vitro. In this regard,
the adult bone marrow has been met with little success, however work from Ihor
Lemischka’s lab in the late 1990’s was able to identify a fetal liver stromal line with
the ability to support the maintenance of HSCs [63]. Although significant advances
have been made in the pursuit to identify HSC governing molecules, there was
previously a lack of evidence regarding the in vivo identification of the specific cells
responsible for these molecules as well as a continued difficulty in isolating such
cells. However, recently significant progress has been made and has begun to
elucidate a more precise location of hematopoietic niches and the regulatory
networks involved in governing HSC behavior.
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Figure 2-4: Schematic representation of hematopoietic microenvironment
(HME). The bone marrow HME is comprised of a diverse group of nonhematopoietic stromal cells, including adventitial reticular cells, stromal progenitor
cells (CFU-F), endothelial cells, osteoblast and adipocytes and hematopoietic
macrophage cells. These cell types generate both critical extracellular matrix and
soluble regulatory molecules governing hematopoietic cell biology. (Modified from
image generated by Nathalie Brouard, PhD)
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2-5: IDENTIFICATION OF THE HEMATOPOIETIC STEM CELL NICHE

Due to the difficulty of studying bone tissue in situ and limitations in
technology, it was not until several years later that a more exact location and cellular
composition of the hematopoietic bone marrow microenvironment began to be
identified [17-26]. Current data suggest that pre-osteoblast cells lining the endosteal
region serve a functional niche referred to as the endosteal niche, while HSCs have
also been found residing adjacent to the sinusoidal endothelial and perivascular
stromal stem/progenitor cells.
THE ENDOSTEAL NICHE
Early reports suggested that the endosteal zone of the bone marrow is highly
enriched in cells which form multi-lineage colonies in the spleens of irradiated mice
making it a candidate location of the hematopoietic niche [64]. A subsequent study
by Nilsson et al. provided additional evidence in support of an endosteal niche, when
labeled HSCs were transplanted and shown to localize to the endosteal region of the
bone marrow [65]. Additionally, in vitro co-culture studies showed osteoblasts
support hematopoietic progenitors [66]. However, a more exact role of osteoblast as
a component of the endosteal niche was later highlighted by two seminal reports.
Using two different genetic models both groups demonstrated that an increase in
osteoblast cells lining the endosteum was followed by a concomitant increase HSC
frequency within the bone marrow [18, 19]. Since these initial reports, many
functional studies have now identified both positive and negative regulators
generated by osteoblasts at the endosteal region, including osteopontin [67, 68],
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angiopoietin-1 [69], thrombopoietin [70, 71] and SDF-1 (CXCL-12) [72]. Several
studies support the role of adhesion molecules such as Jagged-1 and N-cadherin in
establishing direct cell contact between HSCs and cells lining the endosteal surface
[18, 19]. It was proposed that these adhesion molecules where important in
maintaining proper HSC functioning in vivo, however conditional deletion of Jagged1 in bone marrow cells suggests it is not necessary for HSC maintenance in vivo
[73]. Furthermore, Sean Morrison’s group has recently shown that N-cadherin is not
expressed on LT-HSCs [74] and the conditional deletion of N-cadherin in HSCs has
no effect on bone marrow cellularity or the frequency of HSCs [75], suggesting that
N-cadherin is not necessary for maintaining HSCs in vivo. Although the exact
molecular mechanisms underlying the support of HSC by osteoblastic cells remain
to be fully elucidated, there remains significant evidence supporting the role of the
niche in regulating HSC quiescence and maintenance [17, 76].
The Vascular Niche
Throughout ontogeny the sites of hematopoiesis change and interestingly,
data suggest that in each of these developmental stages HSCs share close
interactions with endothelial cells [77]. More recent evidence supports the
hypothesis that embryonic endothelium give rise to multilineage hematopoietic cells,
termed hemogenic endothelium [48, 51, 52, 78]. It is important to note that
hematopoiesis occurs prior to the development of bone during embryogenesis,
which suggests that HSCs are maintained primarily in vascular or perivascular
microenvironments early during ontogeny as well as in areas of extra-medullary
hematopoiesis such as the spleen [78]. Work by Shahin Rafii’s group has led to the
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concept of a proliferative zone surrounding the vascular microenvironment. This
notion is supported by in vitro and in vivo studies that suggest that adult bone
marrow endothelial cells promote the proliferation and differentiation of
hematopoietic progenitors [79] and support the expansion of HSCs in vitro [80].
In 2005, the Morrison lab identified the close association of highly enriched
LSKCD48-CD150+ HSCs with sinusoidal endothelial cells of the bone marrow
suggesting the presence of a vascular niche for regulating HSCs [20]. Recent
reports using CXCL12-GFP knockin [21, 24] and Nestin-GFP transgenic [23] mouse
models have demonstrated that perivascular reticular cells were critical for
maintaining the HSC pool in vivo (Figure 2-5) [23, 24] and selective ablation of these
cells leads to a 50% reduction of phenotypically identified HSCs. However, it is not
clear from these studies if there is an actual decrease in functional HSCs. These
data support previous reports in human BM, which demonstrated that CD146+
subendothelial adventitial reticular cells function as both osteoprogenitor cells (MSC)
and HSC niche constituents [22]. Furthermore, the existence of a
vascular/perivascular niche is supported by the observation that HSCs are rapidly
mobilized into circulation following cytokine treatment [81] and that the regeneration
of sinusoidal endothelial cells following myeloablation treatment is necessary for
hematopoietic reconstitution to occur [82].
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Figure 2-5: Schematic representation of the vascular niche in adult
mouse bone marrow. HSCs are localized directly adjacent to endothelial sinusoids
and are often in direct contact with the cellular processes of adventitial reticular cells
situated along the abluminal surface of vessel sinuses. Additional stromal cells
within the inter-sinusoidal spaces make up a complex stromal reticulum providing a
scaffold for HSC and mature hematopoietic cell migration throughout the bone
marrow.

29

2-7: UNRESOLVED QUESTIONS

To date the exact location, cellular constituents and molecules involved in
regulating hematopoietic stem cells remains a highly contentious and active area of
research. It remains to be determined if two distinct niches exist and if so do they
have different functional roles in regulating HSCs. Recently there has been an
emergence of data using specialized imagining techniques which show the
endosteal zone as being highly vascularized [83, 84]. These findings demonstrate
that the vascular niche containing perivascular stromal cells would lie in close
proximity to the proposed endosteal niche and raise an important question of
whether or not distinct niches exist. It is possible that HSCs are found next to
endothelial and perivascular cells during times of migration in and out of circulation
as well as during homeostasis [15, 25] while only a very minor portion actually reside
along the endosteal surface. However, in light of recent advances in imaging it is
unlikely that HSCs located along the endosteal surface are completely removed from
any potential interaction, be it physical or from soluble molecules, with vascular and
perivascular cells. Data from our own studies presented in this dissertation and
elsewhere have demonstrated that the vascular/stromal system is a vast and
complex network which encompasses the entire bone marrow diameter from one
endosteal surface of a femur to the other, and continues along the full length of a
femur from the hypertrophic cartilaginous zone at the growth plate up to the
trabecular region of the femoral head.
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Although the use of genetic mouse models previously mentioned have proved
useful in identifying perivascular stromal cells that provide critical support for
maintaining HSC behavior, there is little evidence of specific immunophenotypes for
these candidate cell populations which can be used for prospective identification and
isolation. In particular, these mouse models are not commercially available which
further hinders progress in the field by limiting the labs, which can reproduce and
validate these reports. Within the following chapters, I provide evidence of distinct
immunophenotypes, which allow prospective isolation of candidate cell populations,
both stromal and vascular, and data that supports the hypothesis that perivascular
stromal stem/progenitor cells are the major cellular constituents of functionally
critical hematopoietic regulatory molecules.

31

CHAPTER 3:
ISOLATION OF THE STROMAL-VASCULAR FRACTION FROM
ADULT MURINE BONE MARROW [28]
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3-1: PREFACE

In this chapter, I describe a methodology I developed based on a step-wise
enzymatic disaggregation of bone marrow tissue, which led not only to a significant
improvement in the yield of clonogenic stromal cell progenitors (CFU-F) but also
revealed a previously unappreciated complexity in the composition and organization
of cells that comprise the bone marrow stromal compartment [28]. The initial findings
presented within this chapter led us to further hypothesize that the adult mouse
bone marrow contains phenotypically distinct populations of MSC, which
contribute to the maintenance of HSC niches and are prospectively isolatable
by distinct immunophenotypes.

33

3-2: THE NON-HEMATOPOIETIC STEM CELL COMPONENT OF THE BONE
MARROW: MARROW STROMAL STEM CELLS (MSC)

The post-natal bone marrow of adult mammals is comprised of both
hematopoietic and non-hematopoietic cellular elements, each of which is supported
by a specific stem cell population, HSC and mesenchymal stem cells (MSC),
respectively. Thus, not only does the bone marrow harbor two distinct populations of
stem cells, but recent data also suggest that these two stem cells physically colocalize within the marrow, an interaction that is functionally required for the
maintenance of HSC. The anatomical structure of the bone marrow tissue is made
up of highly branched vascular network consisting of arteries, arterioles and large
dilated sinusoids and a heterogeneous stromal cell reticulum of perivascular and
inter-sinusoidal cells, whereby the multitude of hematopoietic lineages reside [55,
56].
The BM stroma encompasses a heterogeneous group of cell types found
between the inner endosteal surfaces of bones and the outer surface of blood
vessels including non-hematopoietic adipocytes, perivascular reticular cells and
osteoblast [26]. Existing within the marrow stromal elements is a rare population of
multi-potent stem/progenitor cells historically referred to as “stromal” stem cells.
More recently, the term “skeletal” or “mesenchymal” stem cells (MSC) [85, 86, 8791] (Figure 2-6) has been extensively used to describe these cells in the literature.
The multi-lineage differentiation capacity of MSC and their corresponding
regenerative potential along with a unique ability to suppress T cell proliferation, has
34

engendered a considerable amount of interest in the potential application of these
cells in a range of cellular therapies.
Circumstantial evidence demonstrating the existence of a non-hemtopoietic
adult stem/progenitor cell within the BM stromal compartment can be found in early
studies by Crosby and colleagues. Following physical or irradiation damage, the BM
stromal tissue was found to undergo a process of complete regeneration [57, 58].
Additional studies demonstrated the osteogenic potential of bone marrow stromal
cells, which were able to generate histologically proven bone ossicles complete with
a surrounding layer of cortical bone and a cavity filled with active hematopoietic
marrow supporting stromal cells and adipocytes following transplantation of
boneless fragments of BM to an ectopic site [26, 92]. Subsequently in a series of
pioneering studies, Friedenstein and colleagues provided a direct demonstration of
stromal stem/progenitor cells by characterizing a population of clonogenic adherent
cells derived from the BM of rodents, which resembled fibroblasts in morphology and
nature leading to the term, colony forming unit-fibroblast (CFU-F) [86, 91, 93]. Since
these initial observations, there has been a considerable interest in identifying the
source of stromal clonogenic precursors in nearly all mammalian tissues examined.
A defining feature of marrow CFU-F is the heterogeneity frequently observed
regarding colony size, an indication of proliferative differences in the founding CFU-F
progeny, and the differentiation potential of individual colonies [86, 88, 120].
Following these observations mentioned above, Owen and colleagues hypothesized
that in the adult BM a stromal cell hierarchy exists, which is constituted of a rare
‘pluri-potent stromal stem cell’ that through the processes of self-renewal and
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differentiation gave rise to the entire non-hematopoietic stromal system (86).
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Figure 3-1: Schematic diagram of bone marrow stromal stem cells
development potential. A rare population of stromal stem cells gives rise to
highly proliferative clonogenic progeny in vitro (CFU-F). CFU-F can undergo
multi-lineage differentiation into osteogenic, adipogenic and hematopoietic
supporting stroma lineages in vivo and generate adipogenic and chondrogenic
progeny in vitro.
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The apparent multilineage differentiation potential of bone marrow stromal
tissue was first illustrated by the seminal studies of Tavassoli and Crosby [92]. In
these experiments, transplantation of bone-free pieces of bone marrow tissue to
ectopic sites generated histologically proven bone ossicles complete with a
surrounding layer of cortical bone and a cavity filled with active hematopoietic
marrow supporting stromal cells and adipocytes. These studies were the first to
reveal the intrinsic osteogenic potential of BM and invoked the existence within the
marrow of a population(s) of cells with the differentiation potential to generate bone
and the other stromal tissues of BM.
Subsequently, early pioneering work by Friedenstein and colleagues
described a population of plastic-adherent, clonogenic progenitors, which, based on
the fibroblastic morphology of their progeny in the colonies, he termed colonyforming unit-fibroblast (CFU-F) [93]. Additional studies by Friedenstein and
colleagues further substantiated Tavassoli and Crosby’s initial findings by
demonstrating the in vivo multilineage differentiation capacity of CFU-F [88, 94].
What was most striking about these studies was that hematopoiesis was maintained
within these ossicles only after bone was formed and vascular endothelial cells of
host origin had invaded the ectopic ossicles, demonstrating a sequence of events
that mimic the developmental events of bone and bone marrow formation [95].
Currently, it is hypothesized that a portion of the founding cells that give rise to CFUF are derived from the subendothelial adventitial reticular cells (Westen-Bainton
cells). Interestingly, this subendothelial region of the marrow sinusoids is not only the
location of the HSC vascular niche, but is also proposed to comprise the stromal

38

stem cell compartment as well. In support of their role as a stromal stem/progenitor
cell in vivo, work from Bianco and colleagues lab demonstrated that some of the
adventitial reticular cells generate mature marrow adipocytes while others give rise
to the more heterogeneous population of bone marrow stromal cells [96].
These studies along with the pioneering work of Dexter and colleagues,
previously mentioned, have provided key insights into the nature and biology of
establishing and maintaining the hematopoietic microenvironment, highlighting the
key role of the non-hematopoietic stromal stem cells in these processes and an
invaluable resource in allowing Ray Schofield to formulate the ‘niche hypothesis’.
Within the hematopoietic stem cell niche field, the stromal stem/progenitor
population is beginning to emerge as the key player in coordinating endogenous
tissue turnover and in establishing and maintaining the hematopoietic
microenvironment.
Although originally identified in mice, many labs have subsequently isolated
BMSCs, some of which contain stem/progenitor activity (MSC), from human, rat,
rhesus monkeys, dog, and pig based on there inherent ability to attach to tissue
culture plastic, undergo limited ex vivo expansion and are able to differentiate into
osteogenic, adipogenic and chrondrogenic progeny in vitro and in vivo (Figure 3-1)
[70-101].
However it is important to note that the majority of progress regarding the in
vivo localization and immunophenotype for prospective isolation of MSC has been
made using human BM samples, with few publications focusing specifically on MSC
derived from mouse BM. This is largely due to the difficulty in isolating
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homogeneous populations of murine BM-derived MSC, a problem exacerbated by
the extreme rarity of CFU-F in murine bone marrow, which furthermore varies with
the mouse strain tested. The reported incidence of CFU-F in C57BL/6 mice, the
strain used for the majority of studies reported in this thesis, is in the range 0.3 2/1,000,000 nucleated bone marrow cells [97, 102, 106]. An additional issue is the
persistence of hematopoietic cells (principally macrophages) that contaminate MSC
cultures derived from mouse BM even after prolonged culture [102-106]. Although
repeated passage of mouse stromal cell cultures has been reported to reduce the
incidence of contaminating hematopoietic cells, a significant drawback of this
strategy is the likelihood of proliferative exhaustion of the low numbers of initiating
CFU-F

progenitor

cells

and

conversely,

the

potentiation

of

spontaneous

transformation of cells following long term culture [107].
Although most data support the low incidence of CFU-F in mouse BM, there
are studies in which significantly higher CFU-F frequencies have been reported
ranging from 35-115/1,000,000) BM cells. This higher colony-forming efficiency is
dependent on the addition of irradiated guinea pig stromal feeder layers [108].
Although the use of feeder cells has only been reported by a single lab, it
nevertheless illustrates an important point that optimal conditions for initiating colony
growth from mouse BM CFU-F have yet to be defined. Additional increases in
CFU-F numbers have been reported following protocols, which involve mechanical
dissociation, and trypsin digestion of the remaining bone marrow clumps as describe
by Freidenstein and colleagues [109].
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Taken

together,

the

low

numbers

of

CFU-F

obtained

by

routine

methodologies, the persistent contamination by hematopoietic cells, the fact that the
majority of mouse BMSC data is based on retrospective analysis of cultured cells,
and the lack of suitable markers of prospective isolation of a purified mBMSC
population, has significantly hindered progress in the mBMSC field, impairing the
ability to address fundamental questions regarding MSC biology through the use of
genetic mouse models but also the development and preclinical testing of proposed
therapeutic applications of MSC in the mouse.
While the majority of labs seeking to understand the nature and biology of
mouse BMSCs use the standard method of flushing BM from long bones, some labs
have attempted to improve the purity of BMSC cultures by additional methodologies
including positive or negative selection and low plating densities [102-106, 109-111]
while other labs have been successful in isolated a sub-population of bone derived
progenitor cells by crushing and digesting compact bone [112-114]. However, these
protocols have not significantly improved the yield of clonogenic progenitors and as
a result have not been standardized nor widely adopted.
We, therefore, sought to develop an alternative strategy for the isolation of
murine BMSC, which would provide a platform to maximally increase the stromal cell
yield and allow populations of BMSCs to be prospectively isolated from freshly
prepared tissue. In developing this methodology, we considered two key points
regarding the structure of the BM stromal-vascular system and the localization of
candidate populations. First, histological studies demonstrate that the BM
hematopoietic microenvironment is organized as a complex network of stroma
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including fibroblastic reticular cells and highly branched vascular arterial and dilated
venous sinuses (references). Second, experimental evidence has demonstrated a
perivascular location of MSC in many adult tissues, including the BM [22, 115].
Early ultra-structural studies of rat BM stroma by Leon Weiss [55]
demonstrated that the reticular cells expand throughout the BM and form a threedimensional reticulum of long cytoplasmic processes that make up the majority of
the marrow parenchyma amongst which hematopoietic cells exist and interact.
Interestingly, some of the marrow cells, which make up the parenchyma are mature
macrophages of hematopoietic origin, while others initially characterized by
membrane bound alkaline phosphatase (ALP) activity are fibroblastic in nature and
are of mesenchymal origin. The ALP positive reticular cells are located within the
intraparenchyma and perivascular along the sinus walls and are often referred to
throughout the literature as Westen-Bainton cells as previously mentioned [116].
Taking both points into consideration along with the delicate nature of the BM
structure, we initially hypothesized that the low frequencies of CFU-F reported by
others is a consequence of the rigorous flushing and trituration of the bone marrow
cavity used to prepare single cell suspensions and that the subsequent destruction
of the marrow vasculature would lead to a diminution in the potential recovery of
stromal stem/progenitor cells localized to perivascular regions along the abluminal
surface of the marrow vessels. In light of our hypothesis, we developed a
reproducible methodology to isolated BMSCs based upon the initial preservation of
the marrow vasculature by first removing an intact plug of BM from the central cavity
of long bones. Single cell suspensions are then prepared by sequential enzymatic
42

digestion of BM plugs, which simultaneously yields both stromal reticular and
vascular endothelial cellular components of the BM. Interestingly, this novel
methodology has facilitated the identification and direct isolation of phenotypically
and anatomically discrete subpopulations of BMSCs. In the following chapters, I
characterize, through well-validated in vivo and in vitro assays, distinct populations
of clonogenic BMSCs that function as both “mesenchymal” stem/progenitor cells
(Chapter 4) and as hematopoietic stem cell niche constituents (Chapter 5).
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3-3: RESULTS

REMOVAL OF INACT BONE MARROW ‘PLUG’ MAINTAINS THE STRUCTURAL
INTEGRITY OF THE MARROW VASCULTURE
Our initial hypothesis was that the mechanical destruction of the marrow
vasculature ultimately destroys the stromal progenitor cells intimately associated
with the vascular walls. To test this hypothesis, we developed an alternative
procedure based on the removal of intact ‘plugs’ of BM from murine long bones by
gentle flushing of the bones with media (Fig 3-2A). This methodology leads to the
removal of the central bone marrow tissue and leaves behind a thin layer of cells
associated with the endosteum region (Fig 3-2 B&C). The marrow ‘plugs’ were then
subjected to a detailed histological analysis of the plugs either embedded in resin or
subjected to whole mount staining. As revealed in Figure 3-2 B, D & E, the marrow
vascular structure remains well preserved, with both arterioles and sinusoids
conserved, and is comparable to BM in situ. Furthermore, whole mount staining of
BM plugs, using a combination of the endothelial cell-reactive antibodies MECA32
and VE-Cadherin, demonstrated a complex vascular network that spans the width of
a femur (Fig 3-2 E). Having confirmed the presence of an intact vascular structure,
we next sought to obtain a single cell suspension from which we could begin to
characterize the various elements of the non-hematopoietic stromal-vascular
fraction.
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Figure 3-2: BM plug isolation and histological assessment of intact vascular
structures in BM plugs. (A) Representative images of denuded bones, removal of
metaphysis and isolated intact bone marrow plug. (B-D) Resin embedded sections
of BM plugs (B&D) and remaining bone tissue (mid-diaphysis) (C) following removal
of marrow plug were sectioned as 5µm thick longitudinal sections and stained with
H&E demonstrates intact vascular structures. (E) Whole mount image of BM plug
stained with a combination of the endothelial cell-reactive antibodies MECA32 and
VE-Cadherin reveals a well-organized vascular reticulum throughout the marrow.
BM plugs were stained with DRAQ5 to provide a nuclear counterstain and then
immersed in prolong gold anti-fade mounting medium (Molecular Probes). After
applying a glass coverslip and sealing with nail hardener, specimens were inverted
and allowed to cure overnight in the dark at RT prior to confocal imaging. Images
were collected using 63x oil immersion objective of a Leica TCS SP5 confocal
microscope and processed with the Leica LAS AF lite software. Z-stacked images
were collected in 0.2 µm slices at depths of 15-25 µm with a pinhole of 1 (x63).
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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We then experimentally determined that three sequential digestions, each of
which was 15 minutes in duration at 37 degrees C (Figure 3-3), with a combination
of collagenase type I and dispase enzymes was sufficient to recover all cells as a
single cell suspension and leaving behind only an acelluar matrix. This point is
further illustrated in Fig 3-4 A, which demonstrates that the total number of nucleated
cells recovered from each digestion as compared to the nucleated cell recovery from
the standard method of rigorously flushing BM is not significantly different.
SEQUENTIAL ENZYMATIC DISAGGREGATION OF BM PLUGS MARKEDLY
ENHANCES THE RECOVERY OF CFU-F
After having determined that three sequential enzymatic digestions was
sufficient to obtain a single cell suspension, we then conducted a series of
preliminary experiments to compare the frequency of CFU-F in sequentially digested
BM (DBM) from each fraction to that obtained by the standard flushing method. As
demonstrated in Figure 3-4 B, each fraction of DBM contained a significantly higher
colony forming efficiency (CFE) than in the flushed BM samples, with a higher CFE
within each successive fraction of DBM. Interestingly, the colony forming efficiency
of CFU-F was on a range of 25 – 40 fold higher from each of the three fractions than
the CFE obtained from an equivalent number of nucleated cells from flushed marrow
samples. Furthermore, these date demonstrate that CFU-F progenitors revealed
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Figure 3-3: Schematic diagram of enzymatic disaggregation of bone marrow
plugs. Intact plugs of BM are gently expelled from the central cavity of long bones
and transferred to an enzymatic solution of collagenase type I and neutral dispase
and incubated in a water bath at 37° C for three sequential rounds at 15 minutes
each. Following each successive round of digestion, the tissue becomes smaller,
more disorganized and pale. Following the third incubation period only an acellular
matrix remains.
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that each fraction of DBM contained significantly more CFU-F than that obtained
from flushed BM, leading to a potential recovery of 3066 CFU-F per femur/tibia pair
to approximately 80 CFU-F recovered from flushed BM, with approximately 62% of
CFU-F being isolated following the first digestion, 31.4% of CFU-F isolated following
the second digestion and 6.9% of CFU-F isolated following the final digestion (Fig. 34 C).
Additionally, we conducted a series of experiments comparing the frequency
of CFU-F obtained by pooling the three fractions together as a more representative
sample of the stromal progenitor population as a whole within BM. Data from these
experiments demonstrated a 196.4 fold increase in the frequency of CFU-F in the
pooled DBM with approximately 1/104 mononuclear cell forming a colony, as
compared to that in flushed BM (Fig 3-4 D). These observations correspond to a
113.95-fold enhancement in the CFU-F recovered by this newly developed
technique and optimized growth conditions at 5% O2 (Fig 3-4 E). In parallel, we also
tested the effects of oxygen concentration of CFU-F formation. To do this, single cell
suspensions of pooled DBM and flushed BM samples were plated in growth media
at either 20% oxygen, normoxia (n=4) or at 5% oxygen, low oxygen (n=8). The CFE
of DBM under low oxygen tension (5%) was nearly 30-fold higher than the CFE of
DBM at normal oxygen tension (20%) (Fig 3-5), signifying perhaps a more
physiologically relevant environment in vitro and a growth requirement in vivo.
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Figure 3-4: Evaluation of clonogenic stromal progenitor cells (CFU-F)
recovered from sequential enzymatic disaggregation of bone marrow plugs.
(A) Average mononucleated cell yields obtained from either standard flushing
methods or from each successive digestion (n=4). (B) Incidence of CFU-F obtained
from either standard flushing technique (5x10^6 mononuclear cells/well) or from
each fraction of digested marrow plugs (2.5x10^5 mononuclear cells/well) plated in
triplicate. (C) Recovery of CFU-F from flushed BM and each fraction of DBM
calculated per femur-tibia pair. (D) Incidence of CFU-F obtained from flushed BM
versus the pool of DBM fractions (1-3) (n=8). (E) Recovery of CFU-F from flushed
BM and the pool of DBM fractions (1-3) calculated per femur-tibia pair. Only colonies
containing >50 stromal cells are scored. CFU-F data are presented both as
incidence of clonogenic cells (CFU-F/1x10^6 mononuclear cells) and as the total
number of CFU-F recovered from a given number of bones (CFU-F per total
nucleated cells). Data are represented as mean + SD. Statistical analysis of CFU-F
incidence was performed with SigmaStat version 3.5 and significance was assigned
to p<0.05.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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Although the increase in DBM CFU-F frequency observed in these
experiments exceeded the CFU-F frequency obtained from flushed BM samples by
at least 2 orders of magnitude, we sought to determine the CFU-F frequency
obtained from DBM samples more quantitatively by limit dilution analysis (LDA). To
do this, single cell suspensions prepared from DBM were plated at a range of
dilutions in 24 replicates (n=3). From these analyses, we observed the frequency of
CFU-F in pooled DBM samples to be 1/2635 BM mononuclear cells (Fig 3-6), which
corresponds to a recovery of 9087.7+2996 CFU-F per femur/tibia pair with a noted
incidence approximately 634-fold higher than that recovered from the same amount
of tissue prepared by flushing BM. Taken together, our data demonstrates that this
newly developed methodology yields significantly more

CFU-F as measured by

both the incidence and recovery as compared to that obtained by standard flushing
of BM samples and represents significance advancement in the study of BM stromal
stem/progenitor cells.
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Figure S1
Figure
3-5: Effect of oxygen tension on CFU-F. Whole bone marrow from

sequential enzymatically disaggregated BM plugs was plated in triplicate at 20%
oxygen (5x10^5 cells/well) or 5% oxygen (2x10^5 cells/well) for 14 days. Colonies
were stained with 0.1% Toluidine Blue.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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Figure 3-6: Limit Dilution Analysis of Bone Marrow CFU-F. CFU-F incidence was
quantified by limit dilution analysis (LDA). Limit dilution assays were performed by
plating bone marrow mononuclear cells at various cell doses (500, 1,000, 2,500,
5,000 and 10,000 cells/well in 24 well plates) with 24 replicates per dilution. Data are
from 3 independent experiments were scored and negative wells enumerated from
each plate at each dilution. Data was analyzed with L-calc software (Stem Cell
Technologies, Vancouver, BC) and plotted as a negative linear relationship to
identify the frequency of colony forming cells.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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PRIMARY

MOUSE

BONE

MARROW

CULTURES

DERIVED

FROM

ENZYMATICALLY DISSOCIATED BM PLUGS CONTAIN THE MARROW
STROMAL-VASCULAR FRACTION
In our initial experiments, we observed that when BM cell suspensions,
prepared by enzymatic disaggregation, were plated at non-clonal densities of 1x10^6
mononuclear cells/cm2 the cultures became 100% confluent by 5-7 days. From this
observation, we next attempted to characterize the immunophenotype of these
primary cultures by testing a number of antibodies directed to extra-cellular
molecules by immunocytochemistry and multi-parameter flow cytometry. We
reasoned that, because the vascular structure was initially intact within BM plugs
(Fig 3-2 B, D&E), these cultures would contain endothelial populations as well as
heterogeneous stromal cell populations. Taking into consideration the fact that
stromal cells and vascular endothelial cells have different in vitro growth
requirements and differential adhesive capabilities to adhere to tissues culture
plastic, we conducted a series of experiments to optimize the growth for each
respective cell type.
For these experiments, DBM was plated at non-clonal cell density (1x106
nucleated cells/cm2) in either αMEM basal media supplemented with 20% fetal
bovine serum on tissue culture plastic or in endothelial basal growth medium
supplemented with a combination of endothelial growth factors (EGM2-MV) on
fibronectin coated tissue culture plates in order to optimize the growth of stromal and
endothelial cell constituents. Following a period of 5-7 days at 5% oxygen in either
growth condition, primary (P0) cultures were first stained in situ with antibodies to
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Figure 3-7: Immunostaining of P0 cultures and isolation and characterization of
BM vascular endothelial cells. (A i-vi) In situ staining of P0 cultures plated on
fibronectin coated chamber slides (LabTek, Nunc, Rochester, NY), cultured in EGM2MV for 5-7 days.

Vascular endothelial cells were identified by staining with a

combination of VE-Cadherin-Alexa 488 and MECA32-Alexa 488 antibodies and
stromal cells were stained with rat anti-mouse PDGFRα/β (purified) antibodies and
revealed with donkey anti-rat Cy3 and counterstained with DAPI. IgG2a and IgG1
isotypes were used for controls (A iv-v). (B) Gating strategy for FACS purification of
vascular endothelial cells from P0 cultures plated on fibronectin coated 10cm2 dishes
at 1x10^6 mononuclear cells/cm2 and cultured in EGM-2MV for 5-7 days and stained
as

described

in

methods.

(C)

Phase

contrast

images

of

LinNEGCD105BRIGHTPDGFRαβNEG cells at passage 3 and functional analysis of
DiAcetylated-LDL uptake. (D) In situ staining of LinNEGCD105BRIGHTPDGFRαβNEG
cells at passage 3 for endothelial markers including VEGFR2 (Di.), VE-Cadherin
(Dii), CD31 and eNOS (Diii), MECA32 (Div), CD105 (Dv) and isotype controls (Dvivii). Nuclei were counterstained DAPI. Imaging was performed on an inverted
fluorescence microscope (Olympus BX51) at both x10 and x40 original magnification
and captured with an Olympus DP71 camera.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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both PDGF receptors, α and β, for stromal cell identification and with a combination
of endothelial specific antibodies to VE-Cadherin, MECA32 and CD31. As shown in
Figure 3-7A (i-vi), we observed discrete staining of clusters of endothelial cells
surrounded by a monolayer of PDGFRαβPOS stromal cells. Interestingly, the size of
endothelial clusters was substantially larger under the more endothelial permissive
growth conditions of fibronectin coating and EGM-MV growth media (data not
shown). When P0 cultures were established from flushed BM cell preparations and
grown

under

identical

conditions,

we

failed

to

identify

any

CD31/VE-

Cadherin/MECA32+ endothelial cells in keeping with our initial hypothesis and were
able to only identify rare colonies (CFU-F) of PDGFRαβPOS stromal cells (data not
shown).
We next used multi-parameter flow cytometric analysis, in order to both
quantify the incidence of stromal and vascular endothelial cells as well as assess the
feasibility of being able to isolate both populations from primary (P0) cultures. By flow
cytometric analysis, we demonstrated that 51.38+16.4% (n=5) of the adherent
population was negative for hematopoietic lineage markers (LINNEG) while
64.68%+15.4% of the LINNEG cells demonstrated staining for PDGFRα and
PDGFRβ, identifying them as stromal cells. Interestingly, the LinNEGPDGFRαβPOS
population exhibited distinct subpopulations when used in combination with the cell
surface marker CD105 (endoglin). These two populations were represented at
nearly equal frequencies with 45.2+2.7% of the cells expressing CD105
(CD105POS) and 43.5+3.6% demonstrated low/negative expression for CD105
(CD105NEG).
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An additional 15.66%+10.6% of the LINNEG cells contained phenotypic properties of
vascular endothelial cells with high levels of CD105 expression and uniformly
expressed CD31, with modest levels of VE-Cadherin and MECA32 staining, while
lacking expression of both PDGFRα and PDGFRβ (Figure 3-7B). While the majority
of hematopoietic lineage negative cells within primary cultures of DBM consisted of
stromal and vascular endothelial cells, the remaining 20% of cells appeared to be
erythroid precursors based on morphology and the expression of CD71 and were
unable to attach to tissue culture plastic (data not shown).
Once having identified an immunophenotype consistent with known
endothelial cell markers, we used Fluorescence Activated Cell Sorting (FACS) to
isolate the LinNEGPDGFRαβNEGCD105bright cells from P0 cultures. Upon isolation, the
cells adhered to fibronectin coated tissue culture plates, displayed characteristic
cobblestone morphology (Figure 3-7C) and were able to undergo limited serial
passaging in EGM2-MV media. At passage 3, the LinNEGPDGFRαβNEGCD105bright
population demonstrated uniform uptake of DiI-Ac-LDL (Figure 3-7C) and continued
to express all endothelial markers tested including VEGFR2, CD31, eNOS, CD105,
MECA32 and VE-Cadherin (Figure 3-7D). Additionally, whole mount staining of BM
plugs revealed an identical immunophenotype as the vascular endothelial cells in
primary cultures identified as LinNEGPDGFRαβNEGCD105BrightCD144POSMECA32POS
(Figure 3-8) and this phenotype can be used in the isolation of endothelial cells from
single cell suspensions based on a lack of hematopoietic lineage cell surface
markers, high expression of CD105 and intermediate levels of VE-Cadherin and
MECA32 and lacking expression of PDGFRαβ (Figure 3-8 B).
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A.

B.

Figure 3-8: Bone marrow vasculature differentially expresses CD105. The
expression of endothelial cell surface markers in vivo was determined by whole
mount staining and flow cytometry. (A) BM plugs were removed, fixed and stained
as a whole mounts with antibodies to VE-Cadherin, MECA32 and CD105. High
powered confocal imaging revealed distinct staining patterns for arteriole and
sinusoidal vessels. Smaller vessels express high levels of VE-Cadherin and
MECA32 and lower levels of CD105 cell surface expression. Larger dilated sinusoid
vessels demonstrate high levels of CD105 staining and low levels of VE-Cadherin
and MECA32 staining. (B) Prospective isolation of BM endothelial cells from DBM
single cell suspensions and phase contrast image of isolated cells demonstrating
cobblestone morphology.
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LINNEG PDGFRαβ NEG CELLS EXHIBIT THE PHENOTYPIC AND FUNCTIONAL
PROPERTIES OF BMSCs
In parallel to using FACS to isolate the endothelial fraction from P0 DBM
cultures, we also isolated the stromal cell population as a whole based on the
LinNEGPDGFRαβPOS phenotype (Figure 3-9A). Upon isolation and serial passaging in
αMEM media supplemented with 20% FBS, the LinNEGPDGFRαβPOS population
exhibited a typical polygonal stromal morphology (Fig 3-9 Bi) and demonstrated
homogeneous expression for both chains of the PDGF receptors, α and β,
consistent with the original phenotype used for their isolation (Fig 3-9 Bii).
Additionally, we used a panel of cell surface markers routinely used by many other
labs to characterize, retrospectively, the adherent population of stromal cells from
mouse BM by flow cytometric analysis. Consistent with the current literature, the
LinNEGPDGFRαβPOS population demonstrated expression of CD29, CD51, CD73,
CD105, CD146 and Sca-1 (Figure 3-9C). However, we did observe considerable
differences in the level of heterogeneity of cell surface phenotypes from cells
obtained by the current enzymatic disaggregation protocol (Figure 3-9D) as
compared to cells obtained by standard method of flushing BM (Figure 3-9C)
analyzed

following

identical

number

of

passages.

Additionally,

the

LinNEGPDGFRαβPOS population isolated from DBM demonstrated a substantially
greater degree of heterogeneity in the cell surface immuno-phenotypes for CD90,
Sca-1 and CD105 (Figure 3-9 B&D), which likely represents a more accurate
reflection of the level of stromal cell heterogeneity seen in vivo.
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Figure

3-9:

Isolation

and

phenotypic analysis of

long-term

cultured

LinNEGPDGFRαβPOS bone marrow stromal cells. (Ai-ii) Representative gating
strategy of viable cells for FACS isolation of LinNEGPDGFRαβPOS cells from P0
cultures. (Aii-iii) Phase contrast image and PDGFRβ immunostaining at passage 3.
(B) FACS analysis of MSC markers in cultures of passage 3 LinNEGPDGFRαβPOS
cells (n=3). FACS analysis demonstrating phenotypic differences between flushed
BM (C) and DBM cells (D). FACS data was collected on BD LSR II and postacquisition analysis was performed with BD FACS Diva 6.1.3. Data are represented
as mean + SD.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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As noted previously, a subpopulation of multipotent stem/progenitor cells
exists within the non-hematopoietic bone marrow stromal cell reticulum [85-91] of
adult mice. These multipotent stem/progenitor cells are hypothesized to be the
founder source for all CFU-F activity and have been shown to contain multi-lineage
differentiation potential by forming histologically proven bone, mature adipocytes,
hematopoietic supportive stroma and cartilage by rigorous in vivo transplantation
assays [91]. We, therefore, sought to evaluate the differentiation potential of the
LinNEGPDGFRαβPOS population obtained as described above. LinNEGPDGFRαβPOS
cells isolated from C57Bl/6mice were collected at passage 3, loaded onto
osteogenic scaffolds (GelFoam®) and allowed to attach for 1-2 days at 37°C at 5%
oxygen. Additionally, empty scaffolds treated identically were used as controls. The
scaffolds were then implanted subcutaneously into immune-deficient (NOD-SCID)
mice by blunt dissection along the dorsal surface.
At 12 weeks post implant, animals were sacrificed, some of which were
subjected to microCT imaging and scaffolds were recovered for histological analysis.
In all scaffolds containing cells (n=8), we observed an outer layer of mineralized
bone tissue surrounding an inner core of bone marrow comprised of donor derived
adipocytes and hematopoietic supporting stroma and host derived hematopoiesis
and blood vessels (Figure 3-10 Aii–iv), whereas control scaffolds (n=6) contained
only fibrous connective tissue (Figures 3-10 Ai).
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Figure 3-10: Multi-lineage differentiation capacity of LinNEGPDGFRαβPOS
BMSCs. (Ai-iv) Histology of subcutaneous transplants of either empty scaffolds (Ai)
or

LinNEGPDGFRαβPOS

MSC

(Aii-iv).

Gelfoam

scaffolds

loaded

with

LinNEGPDGFRαβPOS MSC were either decalcified and embedded in paraffin for H&E
staining (Aii-iii) or non-decalcified and embedded in methylmethacrylate resin for
Von Kossa staining (Aiv). (B) 3D pellet cultures of LinNEGPDGFRαβPOS MSC
embedded in paraffin and stained with Toluidine Blue (0.1% w/v) (Bi), Alcian blue
(Bii), collagen type II (Biv) and mouse IgG1 isotype (Biii). (C) Oil red O staining of
LinNEGPDGFRαβPOS MSC following adipogenic differentiation for 14 days.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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Complementary in vitro differentiation assays were also used to validate the
differentiation potential, whereby the LinNEGPDGFRαβPOS cells demonstrated
robust chondrogenic activity under standard micromass pellet culture conditions as
evidenced by collagen type II expression and the deposition of a sulphated
proteoglycan-rich ECM revealed by staining with Toluidine Blue and Alcian Blue
(Figure 3-10 Bi-iv). In vitro adipogenic differentiation, following exposure to PPARγ
agonists, was also observed in which LinNEGPDGFRαβPOS cells generated prominent
lipid containing vacuoles revealed by Oil Red O staining (Figure 3-10 C).

PROSPECTIVE ISOLATION OF STROMAL PROGENITOR CELLS FROM
FRESHLY PREPARED ENZYMATICALLY DISAGGREGATED BONE MARROW
Collectively, the novel methodology described here demonstrates a robust
reproducible approach as a means to isolate a phenotypically defined BMSC
population as a whole, some of which maintain functional properties of marrow
stromal stem/progenitors cells. We next sought to examine the utility of this
methodology to isolate an identical population within freshly prepared DBM single
cell suspensions given that the above data were obtained from LinNEGPDGFRαβPOS
cells following a brief period of in vitro culture. Single cell suspensions from
enzymatically disaggregated BM, prepared as previously described, were analyzed
by flow cytometric analysis as either whole BM (WBM) or following the removal of
hematopoietic lineage cells using Dynalbeads (Invitrogen). Noticeably, we observed
a discrete population of LinNEGPDGFRα/βPOS cells within WBM from C57Bl/6 and
BALB/c mice (Figure 3-11A), representing 0.087+0.014% and 0.84+0.64%, (n=3)
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respectively. When DBM samples were subjected to immunomagnetic bead
depletion of the hematopoietic lineage positive cells, the frequency of the
LinNEGPDGFRα/βPOS population increased to 51.5% in C57Bl/6 mice and 89% in
BALB/c mice (Figure 3-11B). Upon prospective isolation, the LinNEGPDGFRα/βPOS
population contained the all CFU-F activity and demonstrated colony-forming
efficiencies (CFE) of 0.475% and 2.95% from C57Bl/6 and BALB/c DBM (Figure 311C), respectively. Interestingly in samples prepared by digesting BM from C57Bl/6
and BALB/c mice, we also observed the presence of the PDGFRα/βNEGCD105brght
endothelial cell population in WBM, which was completely absent in samples
prepared by flushing BM (Figure 3-11A). Taken together, these data support our
hypothesis that the flushing of BM leads to a destruction of the marrow vasculature
and a diminution of stromal stem/progenitor cells physically associated with
vasculature surface.
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Figure

3-11:

Prospective

isolation

of

LinNEGPDGFRαβPOS

clonogenic

progenitors from DBM. (A) Gating strategy (left panel) and FACS analysis of whole
bone marrow from C57Bl/6 and BALB/c mice demonstrating the frequency of
LinNEGPDGFRαβPOS bone marrow stromal cells obtained from either standard
flushing or sequential enzymatic disaggregation of BM plugs. (B) Gating strategy
(left panel) for prospective isolation of LinNEGPDGFRαβPOS population from C57Bl/6
and BALB/c inbred mouse strains. (C & D) Incidence of CFU-F from prospective
isolation of LinNEGPDGFRαβPOS BM stromal cells from C57Bl/6 and BALB/c mice.
(Colonies > 50 stromal cells; Clusters represent 10-49 stromal cells).
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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ASSESSMENT OF THE IN VIVO LOCALIZATION OF BONE MARROW
STROMAL CELL RETICULUM
Once having determined the distinct immunophenotype for clonogenic
stromal progenitor cells and vascular endothelial cells, we next sought to determine
the anatomical localization of each population within freshly prepared plugs of BM
using whole mount staining. To do this, we chose a combination of cell surface
markers that where useful for identifying respective cell populations in primary
cultures of DBM by either immunocytochemistry or flow cytometry. We used a novel
whole mount staining methodology with a panel of antibodies directed against known
endothelial cell surface markers including the combination of VE-Cadherin/MECA32
and CD105. Interestingly, we observed a distinct pattern of staining that revealed a
complex vascular network, spanning the entire cross-sectional distance of BM plugs
removed from C57Bl/6 femurs and consisted of arterioles, smaller capillaries and
larger dilated sinusoidal vessels (Figure 3-8A), with sinusoidal endothelial cells
demonstrating the highest staining intensity to CD105.
Additional whole mount samples prepared with the combination of
PDGFRα and PDGFRβ antibodies as pan-stromal cell markers and VE-Cadherin
and MECA32 antibodies for vascular endothelial staining demonstrated a complex
stromal cell reticulum of PDGFRα/βPOS cells with long cytoplasmic extensions
spanning

across

the

hematopoietic

space

and

interacting

with

VE-

Cadherin/MECA32 reactive vasculature (Figure 3-12) and hematopoietic lineage
positive cells (Figure 3-13), while a subset of PDGFRα/βPOS cells were localized to
perivascular regions of VE-Cadherin/MECA32POS arterioles (Figure 12) and CD105
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reactive sinusoids (Figure 3-14) as well as within inter-sinusoidal regions. This
staining pattern, therefore, is useful for identifying the precise localization of
subpopulations of both stromal and endothelial cells and is consistent with our multiparameter flow cytometric analysis used to prospectively isolate the stromal vascular
fraction of mouse BM.
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Figure 3-12: PDGFRαβPOS stromal cells are localized to perivascular and intersinusoidal regions in vivo. Whole mount staining of BM plugs. Vascular
endothelial cells were identified with VE-Cadherin-Alexa 488 and MECA32-Alexa
488 antibodies (I, upper left) and stromal cells were identified with PDGFRα/β
antibodies and revealed with donkey anti-rat Cy3 (ii, lower left). Nuclei were counter
stained with DRAQ5. Z-stack merged image (iii, upper right) and single step merged
image (iv, lower right) identifying perivascular (asterisk) and intersinusoidal (arrow)
localization. Images were collected using a 63x oil immersion objective on zoom
factor of 3 with a Leica TCS SP5 confocal microscope and processed with the Leica
LAS AF lite software. Z-stacked images were collected in 0.2 µm slices at depths of
15-25 µm with a pinhole of 1.
(This research was originally published in Blood Online. Suire C, Brouard N, Hirschi
K, Simmons PJ. Isolation of the Stromal-Vascular Fraction of Mouse Bone Marrow
Markedly Enhances the Yield of Clonogenic Stromal Progenitors. Blood.
Prepublished January 18, 2012; DOI 10.1182/blood-2011-08-372334.)
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Figure 3-13: PDGFRαβPOS stromal cells create a complex stromal scaffolding of
cellular processes interacting with hematopoietic cells throughout extravascular space in vivo. Whole mount staining of BM plugs. Vascular endothelial
cells were identified with VE-Cadherin-Alexa 488 and MECA32-Alexa 488 antibodies
(i, upper left) and stromal cells were identified with PDGFRα/β antibodies and
revealed with donkey anti-rat Cy3 (ii, upper right). Hematopoietic lineage positive
cells (iii, lower left) were identified with the lineage marker panel (see methods table
1) conjugated to biotin and revealed with streptavidin-Alexa 594. Single step slice of
Z-stacked merged image (iv, lower right). Images were collected using a 63x oil
immersion objective with a Leica TCS SP5 confocal microscope and processed with
the Leica LAS AF lite software. Z-stacked images were collected in 0.2 µm slices at
depths of 15-25 µm with a pinhole of 1.
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Figure 3-14: Subendothelial adventitial reticular cells adjacent to sinusoid
vessels are PDGFRαβPOS stromal cells. Whole mount staining of BM plugs.
Sinusoidal endothelial cells were identified with CD105 antibody (i, upper left) and
stromal cells were identified with PDGFRα/β antibodies and revealed with donkey
anti-rat Cy3 (ii, upper right). Nuclei were counter stained with DRAQ5 (iii, lower left).
Single step slice of Z-stacked merged image (iv, lower right). Images were collected
using a 63x oil immersion objective on zoom factor of 2 with a Leica TCS SP5
confocal microscope and processed with the Leica LAS AF lite software. Z-stacked
images were collected in 0.2 µm slices at depths of 15-25 µm with a pinhole of 1.
Arrow-head indicates sinusoidal perivascular PDGFRα/β stromal cell.
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3-4: SUMMARY

Taken together, these data represent a simple and robust methodology that
allows the simultaneous identification and isolation of both the stromal and vascular
cellular components of mouse BM with a yield of CFU-F that far exceeds that
reported in any previous study. Purified BM stromal cell populations devoid of
hematopoietic contamination are readily obtained by prospective isolation and
demonstrate robust multilineage differentiation into bone, adipose and chondrogenic
progeny using standard in vitro bioassays and in vivo transplant models.
Furthermore, by developing a novel whole mount staining methodology, we
are able to obtain a detailed three-dimensional organization of the stromal-vascular
reticulum. This methodology demonstrates the complexity of the stromal system
within the bone marrow and localizes a subpopulation of stromal cells to perivascular
niches while the remaining stromal cells are found to be dispersed throughout the
marrow parenchyma and contain long cytoplasmic extensions which all appear to
contact parts of the vascular structure providing the basis for a cellular scaffolding
for hematopoietic adhesion and migration throughout the BM. By identifying the
respective location and a cell surface phenotype leading to the prospective isolations
of clonogenic progenitors (CFU-F), these studies will greatly enhance experimental
strategies designed to analyze not only MSC identity and function in vivo, but also
the function of the vascular hematopoietic stem cell niche.
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CHAPTER 4:

ISOLATION AND FUNCTIONAL CHARACTERIZATION OF DISTINCT
POPULATIONS OF STROMAL PROGENITOR CELLS
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4-1: PREFACE

In the following chapter, I investigate the identity and nature of the cells in
mouse BM that give rise to cultures of stromal cells most commonly referred to as
mesenchymal stem cells (MSC). I demonstrate, for the first time, that the cells
commonly referred to in the literature as ‘mesenchymal stem cells’ are in fact
derived from phenotypically and anatomically distinct subpopulations of stromal cells
in mouse bone marrow not from a single population of stromal progenitors as implied
by the vast majority of studies published to this point in time.
Much of the field of MSC biology is based on the characterization of culture
expanded stromal cells using panels of antibodies directed at cell surface markers
identified based on their abundant and homogenous expression on these cells. One
such marker is CD105 (endoglin). In the previous chapter, I demonstrated using the
improved methodology for isolation of CFU-F from DBM, that following in vitro
passage up to passage 3 the stromal cells exhibited bimodal expression of CD105
with distinct CD105POS and CD105NEG subpopulations. This was in marked contrast
to cultures established using the standard BM flushing technique, which exhibited
homogeneous CD105 expression in accord with previous reports in the literature.
We postulate that this discrepancy is due largely to differences in the methodologies
employed by investigators to obtain single BM cell suspensions. Specifically, that
flushing of BM results in both quantitative and qualitative reductions in the yield of
stromal progenitors cells and hence does not permit isolation of a stromal cell
population that reflects the phenotypic diversity present in the intact mouse BM.
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In this chapter, I provide evidence that both CD105POS and CD105NEG
subpopulations contain clonogenic stem/progenitor cell activity and both exhibit the
functional properties of MSC as demonstrated by differentiation to bone, adipose
and cartilage tissue using both in vitro and in vivo assays. Finally, transcriptional
profiling was performed on the two subpopulations immediately following their
isolation from the DBM to gain insight into their biological roles in vivo. Analysis of
these data demonstrate that the LinNEGPDGFRαβPOSCD105POS population contains
an over-represented list of genes involved in angiogenesis, blood vessel
morphogenesis and blood vessel development consistent with the role of pericytes.
However, The CD105NEG population contains a list of over-represented genes
involved in biomineralization, ossification and skeletal development suggesting this
population contains cells more committed to the osteoblast lineage and may serve
as a source of direct progenitors for bone formation.
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4-2: INTRODUCTION

In adult mammals, the bone marrow is the place of residence of two
phenotypically and functionally distinct adult stem cell populations. The first of these
are the hematopoietic stem cell (HSC), perhaps the most extensively studied and
best characterized populations of adult or tissue stem cells in all of vertebrate
physiology. The second stem cell population in the BM are non-hematopoietic
multipotent stromal stem/progenitor cells originally identified through the pioneering
studies of Friedenstein and colleagues who first described the multilineage
differentiation properties (bone, cartilage and adipose tissue) of these BM-derived
stem cells through rigorous in vivo transplantation assays [88]. By comparison with
HSC, the non-hematopoietic stromal stem cells are a far less well-understood
population of tissue stem cells. In part this is due to a lack of consistency in the
terms used to describe such cells in the literature such as “osteogenic,” “stromal”
and “skeletal” stem cells. However, the term mesenchymal stem cell (MSC), coined
by Arnold Caplan’s lab in the early 1990’s, has more recently been ascribed to these
cells and is the term most commonly referred to in current literature [117].
The multi-lineage differentiation potential originally identified by the seminal
transplantation studies of boneless fragments of marrow conducted by Tavassoli
and Crosby [92] in the late 1960’s, provided key founding evidence for what would
subsequently emerge as the field of marrow stromal progenitor biology. Shortly
thereafter in the 1970’s, Friedenstein and colleagues described a population of
plastic-adherent, clonogenic stromal progenitors, after which he coined the term
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colony-forming unit-fibroblast (CFU-F) [93], that were responsible for the formation of
ectopic bone and transferring the hematopoietic microenvironment in vivo. It was
proven that this process recapitulates the developmental origin of bone and bone
marrow formation established by cells of mesenchymal lineage during endochondral
ossification [118] and hence the term ‘stromal stem cell’ was born.
Taken together, these data demonstrate that a rare population of bone
marrow stromal cells are both clonogenic in nature and contain the capacity to
generate the diversity of cells found within the adult bone-bone marrow tissue.
Furthermore, in humans it has been demonstrated, at a clonal level, that a single cell
responsible for generating a CFU-F can be expanded in culture and go on to
generate bone, fat and hematopoietic supporting stroma in vivo [119]. CFU-F
derived colonies exhibit considerable morphological, phenotypic and functional
heterogeneity as demonstrated both in vitro and in vivo [86]. The most striking
evidence emerged from the seminal experiments of Friedenstein and colleagues
who transplanted single colonies derived from mouse BM ectopically beneath the
renal capsule in mice. They found that a minor proportion of colonies (approximately
15%) exhibited the capacity to generate a complete bone marrow organ beneath the
renal capsule, comprising a bony ossicle, adipose tissue and a typical marrow
stromal reticulum supporting the associated hematopoietic tissue (the latter derived
from the host mouse) and hence appeared to exhibit a multipotent differentiation
potential. In contrast, the majority of colonies either failed to generate any ectopic
tissue, generated bone tissue only or a fibroblastic connective tissue sometimes
containing adipose cells. Based on these data a hierarchy of stromal cell

84

differentiation has been proposed [86] in which a multipotent self-renewing stromal
stem cell at the apex of this hierarchy gives rise to more committed progenitors with
reduced proliferative potential whose differentiation potential is restricted to one of
the stromal cell lineages of the BM, bone, fat or cartilage (see Figure 3-1). Although,
these data provide evidence that stromal stem cells are clonogenic and multipotent,
it also highlighted a key fact that just as in the hierarchy described for hematopoietic
stem and progenitor cells, clonogenicity per se does not equate to stem cell
potential.
Historically, it has been suggested that a single population of multipotent
stromal progenitors within adult murine bone marrow is responsible for all CFU-F
activity and subsequently are the cells that are able to undergo multi-lineage
differentiation. Initial observations by Westen and Bainton, suggested that
subendothelial adventitial reticular cells expressing membrane bound alkaline
phosphatase [116] were candidate founder cells for CFU-F and subsequent data in
humans demonstrated that these cells generate adipocytes and osteoblasts in vivo
[120]. Additional studies with human bone marrow identified an immunoglobulin
superfamily adhesion molecule, Muc18/MelCAM/CD146 as a cell surface marker of
the population of subendothelial BMSCs. When BM cells exhibiting high levels of
CD146 were isolated by FACS all measurable CFU-F activity was restricted to the
CD146+ fraction and these cells demonstrated the ability to generate ectopic bone
and transfer the hematopoietic microenvironment in vivo. Interestingly, these authors
also provided evidence that only the BMSCs and not bone derived cells, were able
to transfer the hematopoietic microenvironment suggesting that BMSCs contain a
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more primitive stem cell population [22]. Together, these data point to the
subendothelial adventitial reticular cell as the likely in vivo MSC candidate. However,
such experiments have not yet been performed in adult mice and data based largely
on retrospective analysis of culture-expanded MSC is limited by the unproven and
highly unlikely assumption that the pattern of gene expression of the multiply
passaged progeny of MSC in vitro accurately reflects that of the founder stromal
progenitor cell in-situ in the BM. Consequently, data based on analysis of the
phenotypic properties of MSC in vitro cannot necessarily be relied upon to
accurately predict a cell surface phenotype that will allow unequivocal identification
and localization of the in vivo counterpart within the bone marrow tissue.
Recent data using transgenic reporter strains has begun to shed some light
on a candidate subpopulation of stromal stem/progenitor cells in vivo. The
chemokine stromal derived factor 1 (SDF-1/CXCL12) as implied by the name, is
abundantly expressed by bone marrow stromal cells and plays a key physiological
role as a chemoattractant for hematopoietic stem/progenitor cells by virtue of their
expression of the counter-receptor for SDF-1, CXCR4. Using a CXCL12-GFP
knockin model Omatsu et al. [24] demonstrated that GFP+ cells in the BM with their
long cytoplasmic process and anatomical distribution both in association with the BM
vasculature and in the intersinusoidal spaces exhibit features consistent with their
identity as reticular cells. The authors further demonstrated that the GFP+ cells
express alkaline phosphatase in vitro and are able to differentiate into osteoblastic
progeny and give rise to adipocytes in vivo following 5-FU treatment [24]. Recent
work from Frenette and colleagues, using a transgenic mouse model in which GFP
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expression is under the control of the neural-specific regulatory elements of the
nestin gene (Nes-GFP+), demonstrated that GFP+ cells in the BM were localized
exclusively to perivascular regions [23]. In addition, GFP+ cells isolated from the
bone marrow by FACS contained all measurable CFU-F activity and exhibited MSC
activity as demonstrated by standard in vitro differentiation assays and by in vivo
ectopic transplantation experiments. Consistent with the physiological role of Nestin
expressing cells as MSC, when these authors performed lineage-tracing studies
using a nestin-cre/Rosa LacZ mouse model, they identified some contribution to
cartilage and bone in the developing mouse embryo. However, because not all of
the developing bone appeared to be derived from the Nestin expressing cells, it
suggests that there may be additional stromal stem/progenitor populations that also
contribute to the developing bone and may also serve as an alternative source of
resident stem/progenitor populations. Collectively, these two studies shed important
light on the identity of stromal progenitors and in addition, are consistent with the
notion that multiple stromal stem/progenitor populations may exist within adult
murine bone marrow [25].
During bone development, mammals undergo a process of endochondral
ossification where mesenchymal condensation generates hypertrophic cartilage,
which is surrounded by osteoblast progenitors responsible for generating a bony
collar [85, 118]. Following the formation of the outer bone periosteum, vascular
invasion occurs bringing along perivascular cells, which then seed the newly formed
marrow cavity.
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This developmental process has recently been very eloquently demonstrated
by Kronenberg and colleagues using transgenic mouse models. Using two different
mouse models to perform lineage tracing studies, these authors provide evidence
that Osterix expressing precursors give rise to the bone marrow stromal cells,
osteoblasts and pericytes in the developing bone marrow stroma, while more mature
Collagen type I expressing osteoblasts were confined to the perichondrial regions
and never moved into the developing marrow cavity [121]. These data illustrate at a
cellular level that at least some of the adult BMSCs are originally derived from
osteoblast precursors in the developing bone-bone marrow organ. However, it is not
clear from these studies if all of the adult bone marrow MSC and CFU-F are derived
from the Osterix expressing precursor cells. It therefore remains possible that
additional population(s) of cells with the functional properties of MSC remain to be
identified in post-natal adult mouse BM which may differ in their developmental
origins and/or may represent a distinct source of perivascular cells that colonize the
adventitial surface of blood vessels at the time of the initial wave of vasculature
invasion.
One potential source of such cells is suggested by the elegant lineage tracing
studies of Nishikawa and colleagues whose data suggest that some of the stromal
cell compartment is actually developmentally derived from the neural crest [122].
Again using lineage-tracing studies, these authors demonstrate with the use of a
neural crest specific promoter driving expression in a temporal manner of Cre
recombinase, P0-Cre/Rosa-EGFP, that some of the perivascular cells in adult BM
are EGFP+. P0 is a neural crest specific gene active during the wave of neural crest
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migration and is not expressed in WT adult BM. Collectively, these two sets of data
offer an intriguing hypothesis suggesting that BMSCs are derived from at least two
distinct developmental origins.
Despite these recent important advances, the field of mouse BMSC biology is
still beset by many uncertainties with regards to the defining characteristics of MSC
in vivo. Furthermore although often cited, the existence of a hierarchy within the
adult BMSC system within mouse BM remains largely hypothetical and has not been
validated rigorously by retroviral gene marking and transplantation studies that have
proved so powerful in defining the multilineage differentiation potential of HSC. Nor
has it been possible to dissect, phenotypically by prospective isolation of distinct
subsets, the cellular constituents of this supposed stromal stem-progenitor cell
hierarchy as again has been achieved in very great detail in the hematopoietic
system [reviewed in 3].
In the previous chapter, a novel methodology that greatly increases the yield
of clonogenic stromal stem/progenitor cells was described that simultaneously
allows for the prospective isolation of the stromal/vascular fraction from murine bone
marrow. By means of this methodology we have identified subpopulations of stromal
cells based on their distinct immunophenotypes, which have not been previously
reported and whose physiological roles consequently remain unknown. The studies
described in the following chapter have begun to resolve the identity and function of
these distinct populations of stromal stem/progenitor cells. Here, I describe the
isolation and characterization of distinct populations of clonogenic BMSCs with
stem/progenitor properties by fractionating the LinNEGPDGFRα/βPOS population using
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of the TGF-β family co-receptor, endoglin (CD105). Through various lines of
investigation using both in vitro bioassays and in vivo transplantation studies, I
demonstrate

that

the

LinNEGPDGFRα/βPOSCD105POS

and

LinNEGPDGFRα/βPOSCD105NEG populations each contain independent clonogenic
progenitors with the ability to generate ectopic bone and bone marrow. By means of
transcriptional profiling of the prospectively isolated populations, evidence is
provided consistent both with distinct anatomical localization in vivo and of
potentially different biological functions. Such data form the basis of future
experimental approaches to define putative stromal cell hierarchies in the mouse BM
stromal cell system.

90

4-3: RESULTS

Distinct populations of bone marrow stromal cells initiate both long-term
stromal cell cultures and generate all CFU-F activity
We have previously identified a composite phenotype for the BM stromal cell
population as a whole in fresh marrow based on the lack of hematopoietic lineage
markers and expression of both the alpha and beta chains of the PDGF receptors
(LinNEGPDGFRα/βPOS) [28], which interestingly exhibited a bimodal expression for
CD105. We next sought to determine if stromal cell clonogenic activity could be
further enriched for based on CD105 (endoglin) expression as suggested by most
retrospective analysis in the reported literature. Within both primary cultures and in
freshly prepared DBM samples, we identified a LinNEGPDGFRαβPOSCD105POS
(referred to throughout as CD105POS) and a LinNEGPDGFRαβPOSCD105LOW/NEG
(CD105NEG) population. We therefore asked the question whether or not these two
populations exhibit different functional properties.
Primary cultures of BMSCs were obtained from enzymatically disaggregated
BM plugs and plated at either nonclonal (1x10^6 cells/cm2) or at clonal densities
(1x10^4 cell/cm2). In both cases, flow cytometric analysis demonstrated that clonal
and non-clonal cultures exhibited a bi-modal expression for CD105 within the
LINNEGPDGFRαβPOS stromal cell population at nearly equal frequencies (Figure 4-1A
i-ii), with no significant difference in the percentage of each population. At nonclonal
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Figure 4-1: PDGFRαβ POSCD105POS and CD105NEG cells initiate whole bone
marrow CFU-F cultures. (A) Representative flow cytometric analysis of primary
cultures of DBM plated at non-clonal and at clonal densities demonstrates equal
frequency of each population within the hematopoietic lineage negative cells. (B)
Quantification of flow cytometric analysis for CD105POS and CD105NEG populations.
(C) Representative in situ immunocytochemical staining of individual CFU-F colonies
demonstrates homogeneous expression for CD105 within individual CFU-F. (D)
Quantification of CFU-F in situ staining from 3 independent donors plated in
triplicate. A total of 12 colonies were scored per donor. Data represent mean + S.D.
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density, the CD105POS fraction represents (45.2+ 2.65%) of the LinNEGPDGFRαβPOS
population and the CD105NEG fraction represents (43.5+ 3.6%) of the population by
flow cytometric analysis (Figure 4-1A i). Interestingly, when BM mononuclear cells
were plated at clonal density, the CD105POS and CD105NEG populations were
represented at nearly equal frequencies within the LINNEGPDGFRαβPOS population,
48.2+ 15.03% and 40.0+ 12.5% respectively. In addition, in situ staining of primary
cultures of DBM derived CFU-F revealed that single colonies were either all reactive
or all negative for CD105 (Figure 4-1C), demonstrating that both CD105POS
(44+19.6%) and CD105NEG (56+19.7%) cells initiate CFU-F colonies from whole
bone marrow (Figure 4-1 A-D), with no significant difference in the number of
colonies generated.
Next, we sought to determine the frequency of CFU-F generated within each
population from freshly prepared DBM samples. By flow cytometric analysis, the
CD105POS population represented significantly more of the LinNEGPDGFRαβPOS
fraction with averages of 44.3% and 63.9%, in C57Bl/6 and BALB/c mice,
respectively while the CD105NEG population represented 23.7% and 16.7% in the
same two strains (Figure 4-2 B). As shown in Figure 4-2 C, both the CD105POS and
CD105LOW/- populations generate CFU-F, when prospectively isolated, however the
CD105POS population contained significantly more CFU-F per 1000 cells plated in
C57Bl/6 mice suggesting that this population is more enriched in CFU-F activity
(Figure 4-2C). However, the difference in the number of CFU-F formed from each
prospectively isolated population was not statistically different in BALB/c mice
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Figure

4-2.

LinNEGPDGFRαβ POSCD105POS

and

CD105NEG

populations

prospectively isolated from digested BM plugs are highly enriched in CFU-F
activity. (A) Prospective isolation of CD105POS and CD105NEG populations from
enzymatically prepared BM plugs in C57Bl/6 and BALB/c mice. (B) Quantification of
the percentage of viable cells gated through hematopoietic lineage negative
population. (C) Number of CFU-F colonies generated from sorted populations in
C57Bl/6 and BALB/c mice.
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highlighting a difference in the two strains of mice. Interestingly, this purification
strategy for CFU-F isolation yields a 50-100 fold increase in the CFU-F obtained as
compared to unfractionated whole BM samples. And while the percentage of the
CD105POS population in vivo represents at least 50% more of the total
LinNEGPDGFRα/β population (Figure 4-2 A&B), this observation suggests that it is
more heterogeneous in terms of clonogenic activity and potentially function. Taken
together, these data demonstrate that phenotypically distinct subpopulations of
clonogenic stromal progenitor cells exist within mouse BM in vivo and equally
contribute to the generation of CFU-F in culture.
Having previously noted that the bimodal expression of CD105POS and
CD105NEG exists within total BM cultures up to passage 3 (Figure 3-9 B&D), we next
wanted to determine if this bimodal expression would persist long term in culture
over multiple additional serial passages or would change over time. To perform
these experiments, DBM was plated in culture at non-clonal dilutions and multiparameter flow cytometric analysis was conducted following serial passaging at P0,
P3, P6 and P9. We observed a significant and progressive increase in the
percentage of CD105POS cells in the cultures after passage 3 and by passage 9, the
entire LINNEGPDGFRαβPOS fraction homogenously expressed CD105 (Figure 4-3
A&B).
This data suggests one of three possible scenarios; 1) a hierarchy exists
whereby the CD105NEG cells represent a more primitive population that give rise to
CD105POS cells more representative of a committed progenitor (Figure 4-4A);
scenario 2) CD105POS cells have a greater proliferative capacity in vitro and
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eventually overtake cultures following serial passaging (Figure 4-4B); or scenario 3)
all stromal cells begin to express CD105 following extended culture periods
representing an in vitro artifact (Figure 4-4C). To begin addressing each possible
scenario, DBM single cell suspensions were fractionated by FACS into CD105POS
and CD105NEG populations, and analyzed for their expression of CD105 by flow
cytometric analysis following serial passaging. Up to passage 6, we were unable to
detect any level of inter-conversion between these two immunophenotypes (Figure
4-5) suggesting that distinct subpopulations within the bone marrow stromal
compartment can initiate and maintain long-term marrow cultures, ruling out the
likelihood of scenarios 1 and 3, and suggesting that CD105POS cells contain a
greater proliferative capacity in vitro and eventually overtake cultures of
unfractionated WBM. In support of this, the CD105NEG population failed to proliferate
beyond passage 6, at which time the majority of cells became large flattened binucleated cells that stop dividing while at the same passage history, the
CD105POSpopulation continued to proliferate at least to passage 9.
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Figure 4-3. DBM cultures demonstrate homogeneous for CD105 expression
following ex vivo expansion. (A) Representative FACS plots of whole bone
marrow cultures prepared from enzymatic disaggregation of BM plugs. Gating is set
according to isotype controls (B) Quantification of flow cytometric analysis
demonstrating an increase in frequency of hematopoietic lineage negative cells and
CD105POS cells concomitant to a complete loss of the CD105NEG population. Data
are represented as the mean + Std. Dev. n=3. Statistical analysis was performed
with student t-test and significance assigned to p<0.05 (*), and p<0.0001 (**).
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Figure

4-4:

Schematic

diagram

of

possible

explanations

leading

to

homogeneous CD105 expression following extended culture. (A) Scenario 1:
existence of a stem/progenitor hierarchy with CD105NEG population representing a
more primitive stem/progenitors with limited self-renewal capabilities which undergo
asymmetric divisions giving rise to more committed CD105POS progenitors. (B)
Scenario 2: CD105POS cells demonstrate a greater proliferative capacity and overtake cultures following extended passage history. (C) Scenario 3: All BMSCs begin
to express CD105 following increasing passage history.
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Figure 4-5: LinNEGPDGFRαβ POSCD105POS and CD105NEG cells fractionated from
freshly prepared BM samples maintain their original CD105POS or CD105NEG
phenotype in culture. Flow cytometric analysis demonstrating maintenance of the
input phenotype with respect to CD105 expression following serial in vitro passage
of mouse DBM derived BMSC.
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A subpopulation of prospectively isolated LinNEGPDGFRα/βCD105POS cells coexpress mature pericyte and subendothelial adventitial reticular cell markers
in vivo
Although all CFU-F are contained within the CD105POS and CD105NEG
fractions, not all cells expressing either of these markers are able to form CFU-F
suggesting that each population remains heterogeneous in regards to clonogenic
activity. To further assess the level of heterogeneity within each population, we
prospectively isolated LinNEGPDGFRα/β population as a whole by FACS and cells
were used to prepare cytospins and dual labeled for CD105 in pair-wise combination
with a panel of pericyte/mural cell markers, including NG2, alkaline phosphatase
(ALP) and α smooth muscle actin (αSMA). Accordingly, the CD105POS and
CD105NEG populations were represented at nearly equal frequencies by cytospin,
57.9% and 41.6%, respectively, as that determined by flow cytometric analysis
validating the use of this approach (Figure 4-6B). 100% of the cells exhibited
staining with antibody to PDGFRβ, as expected, confirming the purity of the sorted
cell population (Figure 4-6 A v&vi, & B). The percentage of CD105POS cells
exhibiting co-staining for these additional pericyte/mural cell markers is represented
in Figure 4-6B. Approximately 18% and 28%, respectively, of CD105POS cells
expressed αSMA and NG2, suggesting that a minor subpopulation of cells within this
phenotype are smooth muscle/perivascular cells. Conversely, all of the cells that
expressed either αSMA (A vii-ix), NG2 (A x-xii) or ALP (A xiii-xv) were also positive
for CD105 (white arrows), demonstrating that cells exhibiting expression of the well

101

documented

pericyte

markers

αSMA

LinNEGPDGFRα/βCD105POS subpopulation.
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and

NG2

are

restricted

to

the

Figure 4-6: Prospectively isolated LinNEGPDGFRαβ POSCD105POS cells coexpress pericyte/mural cell markers in vivo. (A i-xvi) Representative images of
Immunohistochemistry staining of prospectively isolated PDGFRα/βPOS cells with a
combination of cell surface markers to CD105, PDGFRβ, αSMA, NG2 and Alkaline
Phosphatase or isotype controls. PDFGRβ was used as a positive control
demonstrating 100% of sorted cells expressing PDFGRβ (A v-vi). A subpopulation of
CD105POS cells (white arrows) express αSMA (A vii-ix), NG2 (A x-xii) and ALP (A
xiii-xv). Isotype controls: Rb-IgG, Ms-IgG and Gt-IgG isotype controls (A i-iii). Nuclei
were counterstained with DAPI in prolong Gold anti-fade mounting media. Images
were captured on am Olympus 70x epifluorescent microscope with an Olympus
camera under identical exposure time at 40x magnification. White arrows indicate
double positive cells for CD105 and αSMA, NG2 and ALP. Yellow arrowheads
indicate CD105NEG cells lacking expression for any additional markers tested. (B)
Quantification of cells expressing each marker from 3-5 fields of view per slide. Data
represent mean + Std. dev. (C & D) Flow cytometric analysis of transgenic mouse
strains demonstrating expression of αSMA (C) and NG2 (D) within the CD105POS
population. (E) Whole mount staining of WT BM plugs demonstrating a perivascular
localization of PDGFRα/βPOSNG2POS cells along smaller arteriole vessels consistent
with mature pericyte function in vivo. Images were captured using a 63x oil
immersion objective of a Leica TCS SP5 confocal microscope and processed with
the Leica LAS AF lite software. Z-stacked images were collected in 0.2 µm slices at
depths of 15-25 µm with a pinhole of 1 (x63).
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We next validated these results by flow cytometric analysis of two different
transgenic mouse models, the first in which the αSMA promoter drives expression of
RFP (αSMA-RFP; generously supplied by Dr Frank Marini, MD Anderson Cancer
Center, Houston, TX) and the second strain in which the NG2 promoter drives
expression of DsRed (Tg(Cspg4-DsRed.T1)1Akik/J [124]) (Figure 4-6 C&D). From
each strain BM plugs were isolated and subjected to sequential enzymatic
disaggregation as previously described to yield a suspension of DBM which was
then analyzed for either RFP or DsRed expression (as appropriate) in combination
with the Lineage panel, PDGFRα/β and CD105.
This approach confirmed the immunocytochemistry data demonstrating that
all of the αSMA-RFP and NG2-DsRed expressing cells fell within the CD105POS
fraction, representing 7.1% and 4.2%, respectively (Figure 4-6 C&D). Additionally,
whole mount staining of BM plugs was performed to determine the in situ localization
of NG2 positive cells within the BM. From this staining, we observed that the
PDGFRα/βPOSCD105POSNG2POS cells were localized to smaller blood vessels which
were reactive for both VE-Cadherin and MECA32 antibodies (Figure 4-6 E), a finding
consistent with the known localization of pericytes [125]. Importantly, the
PDGFRa/bPOSCD105POSNG2POS population was also assayed for its content of
CFU-F and exhibited a CFE of 0.4% (4 colonies/1000 cells plated). Interestingly from
the same mice, the LinNEGPDGFRa/bPOSCD105POSNG2NEG population contained a
colony forming efficiency of approximately 1.2%. Taken together these data
demonstrate that differential expression of CD105 allows the resolution of the
stromal progenitor population of mouse BM into subpopulations that differ in their
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phenotype and anatomical location within the BM and implies that they may be
hierarchically related.
LinNEGPDGFRα/βCD105POS and CD105LOW/- populations exhibit multi-lineage
differentiation in vitro and generate ectopic bone tissue with associated
hematopoietic bone marrow in vivo
We next, assessed the differentiation potential of the each population through
a series of in vitro and in vivo differentiation assays. For these experiments, DBM
from freshly prepared BM was fractionated based on LinNEGPDGFRα/βPOSCD105POS
and CD105LOW/- phenotypes by FACS and expanded to passage 3. At passage 3 or
4, each population was first subjected to in vitro multi-lineage differentiation assays.
To assess differentiation along the osteogenic lineage, cultures were plated in basal
medium for 2-3 days and followed by exposure to the standard osteogenic
differentiation culture conditions (ascorbic acid, dexamethasone and inorganic
phosphate; see Materials & Methods) for 14 days. At day 14, cultures were fixed and
histochemical staining performed to reveal alkaline phosphatase activity as a marker
of osteoblastic differentiation in combination with calcium-phosphate mineralized
deposits (revealed using the von Kossa reaction). Under these conditions, both
CD105POS and CD105NEG populations efficiently differentiated along the osteoblastic
lineage (Figure 4-7A top panel). Additionally, when confluent cultures were grown in
the presence of the PPARγ agonist IBMX for 14-21 days, both populations
successfully differentiated along the adipogenic lineage containing clusters of
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Figure 4-7: LinNEGPDGFRαβ POSCD105POS and 105NEG populations contain MSC
activity in vitro. (A) In vitro multi-lineage differentiation of CD105POS and 105NEG
populations. Osteogenic lineage differentiation was evaluated by alkaline
phosphatase (blue) and Von Kossa (brown) staining. Adipogenic lineage
differentiation assessed by Oil red O staining of lipid vacuoles. Chondrogenic
lineage differentiation was assayed in micro-mass pellet cultures and stained with
Toluidine blue.
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lipid-laden cells that stained with the neutral lipid stain Oil Red O (Figure 4-7 B
middle panel). Chondrogenic differentiation was evaluated using standard
micromass pellet culture assays. In these assays, both populations were able to
generate chondrogenic pellets, revealed by the deposition of a sulphated
proteoglycan-rich ECM stained with Toluidine Blue (Figure 4-7, bottom panels).
These data provide evidence that both CD105POS and CD105NEG stromal cell
subpopulations exhibit the capacity for multilineage differentiation to generate
osteoblastic, adipose and chondrogenic progeny in vitro.
Although in vitro differentiation assays are readily used by many labs to
assess multi-lineage differentiation potential, caution must be exercised in
interpreting these assays since in vitro differentiation potential does not
unambiguously predict their capacity for differentiation in vivo [126]. Therefore, we
further tested the multipotency of each population using rigorous in vivo
transplantation assays to determine the differentiation potential of the CD105POS and
CD105NEG populations. For these assays, DBM cell suspensions were prepared from
C57Bl/6 mice and fractionated by FACS on CD105POS expression. Following
isolation, each population was expanded in culture to passage 3 or 4, at which time
a portion of the cells were analyzed by flow cytometric analysis to validate the input
pre-transplantation phenotype (see Figure 4-9 A). The remaining cells were loaded
onto Gelfoam scaffolds at 5x10^5 cells/scaffold and implanted subcutaneously by
blunt dissection into NOD-SCID mice as previously described [85, 88]. Initially,
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Figure 4-8: LinNEGPDGFRαβ POSCD105POS and 105NEG populations generate
ectopic bone and transfer the hematopoietic microenvironment in vivo. In vivo
ectopic bone tissue with associated hematopoietic bone marrow. Top panel
represents empty scaffolds as controls (n=6), middle panels are representative bone
formation from CD105POS population (n=8) and lower panel is from CD105NEG
population (n=8) stained with H&E and Von Kossa (left to right).
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scaffolds were recovered at 12 weeks post implant for histological evaluation. In all
cases (8 out of 8), scaffolds contained an outer core of mineralized bone tissue
surrounding an adipose rich BM tissue (Figure 4-8, middle and bottom panels)
whereas only fibrous connective tissue was observed in mice transplanted with
empty scaffolds as controls (n=6) (Figure 4-8, top panels). Thus both murine BM
stromal stem/progenitor subpopulations also demonstrate the capacity to form
histologically proven bone tissue and transfer the hematopoietic microenvironment in
vivo.
While these data provide evidence that both LinNEGPDGFRαβPOSCD105POS
and 105NEG stromal progenitor subpopulations demonstrate the capacity to generate
an ectopic bone marrow organ it should be noted the transplants were performed
using equivalent numbers of cells from each population and the formation of a bony
ossicle was assessed at the one time point. This experimental design therefore does
not preclude the possibility that the two populations may differ either in their potency
or in the kinetics with which they each generate an ossicle. Furthermore this
experimental approach also does not measure whether differences in the selfrenewal potential of the two populations exist as would be demonstrated by
secondary CFU-F formation and the generation of secondary bone-marrow ossicle
upon secondary transplantation.
To begin to address such questions a series of studies were designed using
the heterotypic bone ossicle forming assay in which fewer input cells were
transplanted and the transplants were of shorter duration. For these studies, BMSC
subpopulations were isolated from UBC-GFP mice (n=6 per group) in order to track
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the fate and contribution to bone formation and hematopoietic supporting stroma by
transplanted donor derived cells. Furthermore, the use of labeled cells facilitated
analysis of the phenotype of the transplanted cells and the potential to re-isolate
donor cells following transplantation by means of FACS. Previous experiments
suggested that the CD105POS cells exhibited a greater proliferative advantage in
culture (Figure 4-4) and generate significantly more CFU-F colonies (Figure 4-2 C)
as well as generate qualitatively more larger colonies than CD105NEG cells further
supporting evidence of a greater proliferative advantage in vitro (Figure 4-9 A i-iii).
To address the issues of potency and kinetics, CD105POSGFPPOS and
CD105NEGGFPPOS cells were isolated from UBC-GFP mice as previously described
and a some of the cells were plated for CFU-F assays to again confirm the
clonogenic potential (Figure 4-9 Ai-iii) and the majority of isolated cells were
expanded in culture to passage 3. At which time, cells were collected and a portion
of the cells from each population were analyzed by FACS to confirm the pretransplantation immunophenotype (Figure 4-9 B) and the remaining cells were
loaded onto Gelfoam scaffolds and transplanted subcutaneous as previously
described.
At 12 weeks post-transplant, mice were sacrificed and subjected to MicroCT
analysis to identify bone containing ossicles macroscopically (Figure 4-9 C).
Scaffolds were then recovered and processed for histology following decalcification.
H&E staining of scaffolds further demonstrated ectopic bone formation and GFP
immunohistochemistry was used to confirm the contribution from donor-derived
cells. In these experiments, both populations demonstrated contribution to
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osteoblast bone lining cells, mature osteocytes embedded in bone matrix, immature
adipocytes containing multiple lipid droplets and immature, unilocular adipocytes
(Figure 4-9 D). Furthermore, some scaffolds were crushed, enzymatically digested
and the cells recovered by this process subjected to flow cytometric analysis. In
these studies, scaffolds recovered from CD105POSGFPPOSdonor cells demonstrated
a bimodal expression for CD105 similar to the distribution seen in freshly prepared
tissue (Figure 4-9 Ai), with 58.6% of the cells retaining CD105 expression and 40.5%
of the GFPPOS cells expressing low to negative levels of CD105 expression (Figure
4-9 E i&ii). However, CD105NEG donor cells remained negative for CD105
expression (4-9 E iv&v). Interestingly, when cells recovered from these scaffolds
were plated at equivalent numbers in culture for secondary CFU-F assays we were
only able to find colonies from scaffolds derived from the CD105POS donor cells
(Figure 4-9 Eiii), where as the CD105NEG donor cells grew scattered throughout the
well without any evidence of colony formation (Figure 4-9 E vi). We were not able to
accurately enumerate the colonies in this experiment due to overgrowth of host
GFP-Neg fibroblasts in the tissue surrounding the implants.
Nevertheless, these data represent important evidence suggesting that
following transplantation in vivo, CD105POS cells generate both CD105POS cells and
CD105NEG subpopulations but under identical transplant conditions, CD105NEG cells
only give rise to CD105NEG cells. These results imply that CD105POS and CD105NEG
are not independent self-maintaining populations but represent a hierarchy of
BMSCs.
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To address the issue of potency and kinetics, BMSCs fractionated as above
on the basis of CD105 expression were again loaded onto scaffolds and
transplanted subcutaneously at a dose of 1x10^5 cells per scaffold and transplanted
for a total of 6 weeks (n=4). Histological analysis of these scaffolds demonstrated
that although both populations generated bone tissue, only the CD105POS cells were
able to generate adipose derived marrow (Figure 4-10 A), whereas the CD105NEG
cells contributed mostly to bone formation (Figure 4-10 B) with only 1 of 4 scaffolds
demonstrated a small area of marrow adipocytes. Because these transplantation
assays were done with fewer input cells and for a shorter duration of time, these
results suggest a potential difference in the potency of stem/progenitor cells within
the two populations in vivo and in their differentiation kinetics.
Together, these transplantation studies demonstrate that although both
populations contain clonogenic progenitors that are able to form ectopic bone at
5x10^5 cells per graph during a 12 week time point, the CD105POS population
exhibits greater proliferative potential in vitro and in vivo and suggest that this
population as a whole is more enriched in primitive stromal stem cells as
demonstrated by their ability to generate both bone and adipose rich bone marrow
from fewer cells in a shorter period of time in vivo. Our preliminary data also suggest
that the capacity to form secondary CFU-F (as a measure of self-renewal capacity)
following ectopic transplantation is restricted to the CD105POS subpopulation.
Additionally, because CD105POS cells give rise to CD105NEG cells in vivo in the
heterotypic bone forming model, we reasoned that within the CD105POS population
exists a hierarchically more primitive stromal stem cell, which sits atop of
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Figure 4-9: LinNEGPDGFRαβ POSCD105POS population contains stromal
stem/progenitors with secondary CFU-F generating potential. (A)
Representative FACS plot (i) and CFU-F images (ii-iii) from each population
following prospective isolation. CD105POS (ii) population contains founder CFU-F
with greater proliferative advantage compared to CD105NEG (iiii). Arrows highlighting
qualitative difference in colony size. (B) Pre-transplantation immunophenotype of
passage 3 culture expanded CD105POS and CD105NEG populations. (C) Micro CT
imaging of subcutaneous scaffolds at 12 weeks post-transplant. Arrows indicate
ectopic bone. (D) GFP immunohistochemistry of recovered scaffolds demonstrating
donor derived bone and adipogenic marrow stoma. (E) Ectopic scaffolds were
recovered, digested and analyzed by flow cytometric analysis and CFU-F assay. (Ei
& iv) GFP expression of donor cells recovered from scaffolds. (E ii & v) Flow
cytometric analysis of GFP+ donor cells following 12 weeks post-transplantation
demonstrating CD105POS donor cells generate CD105LOW/NEG cells in vivo. (E iii & vi)
GFPPOS cells plated from scaffolds demonstrating secondary CFU-F potential by
GFPPOSCD105POS donor cells.

115

116

a stromal cell hierarchy.
Although this proposed hierarchical model in the adult BM is largely
speculative at this time, it is supported by studies from the Weissman lab using fetal
bone-derived stromal cells [123]. This study described the ability of fetal bone
derived stromal cells fractionated on CD105 and Thy1 expression to establish a
stem/progenitor cell hierarchy in which CD105POSThy1NEG cells generated bone and
HSC supporting BM in a kidney capsule ectopic transplant model while the
CD105POSTHY1POS and CD105NEG populations generated bone tissue only.
Furthermore, the authors provide evidence that the CD105POSTHY1NEG population
follows the process of endochondral ossification, while the CD105POSTHY1POS
population, expresses 5 fold higher levels of osteocalcin and appears to form bone
without the cartilage intermediate [123].
Global transcriptional analysis of BM stromal stem/progenitor populations
After having established the existence of phenotypically distinct
subpopulations that contain functional clonogenic osteoprogenitor cells, we next
sought to determine if transcriptional profiling would provide additional evidence as
to their biology and/or potentially point to a stromal stem/progenitor cell hierarchy.
For these experiments, the LinNEGPDGFRα/βPOSCD105POS and
LinNEGPDGFRα/βPOSCD105NEG stromal cell populations and hematopoietic lineage
positive cells were prospectively isolated from three independent experiments.
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Figure 4-10: Time dependent developmental potential of ectopic bone and
bone marrow formation by subpopulations of BMSCs. The development of bone
and bone-bone marrow tissue in ectopic sites is dependent on time and number of
cells. (A & B) Representative images of scaffolds stained with H&E following 6
weeks post-transplant. (Ai-ii) CD105POS scaffolds demonstrate the formation of bone
and adipose rich bone marrow by 6 weeks, whereas CD105NEG scaffolds contain
only bone. By 12 weeks (C&D), both populations form bone and adipose rich bone
marrow tissue. Boxes indicate regions imaged at 20x magnification.
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Endothelial cells were removed from the isolation strategy based on the
CD105brightPDGFRαβNEG immunophenotype previously identified (see Figures 3-7 &
3-8). Total RNA was extracted from each population and subjected to gene
expression profiling using the Illumina Sentrix Beadchip Array Mouse WG-6.v2
arrays. To ensure the purity of each population following isolation, post sort analysis
was performed for each group and demonstrated purities for CD105POS at
97.4+1.9% and CD105NEG at 94.1+2.5%.
Following hybridization and detection, we compared the genes in common to
both stromal cell populations that were expressed at least two fold greater with a pvalue <0.01 to the genes expressed in hematopoietic lineage positive cells. From
this analysis, we identified 1,798 annotated genes that were differentially expressed
between stromal cells and all hematopoietic cells. As expected, the stromal cell
populations demonstrated a clear mesenchymal signature in gene ontology analysis
by DAVID (Table 4-1). A number of surface markers, extracellular matrix molecules
and signaling pathways characteristic of mesenchymal cells were highly overrepresented within these two populations consistent with known stromal cell biology
(Table 4-2). Of interest, GO functional annotation analysis yielded an over
representation of genes involved in signaling pathways (493 genes), secreted
molecules (226 genes), ECM proteins (86 genes), cell adhesion molecules (108
genes), skeletal system development (74 genes), blood vessel development (62
genes), mesenchymal cell development (12 genes), and growth factors (26 genes).
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Table 4-1: Genes expressed in LinNEGPDGFRαβ POSCD105POS and 105NEG
populations as compared to all hematopoietic cells by microarray and gene
ontology analysis
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Table 4-2: Gene Ontology functional annotation of over-represented gene list
in stromal cells as compared to hematopoietic cells by DAVID
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Additionally, PDGFRα and β was highly expressed within the stromal cell fraction
consistent with the immunophenotype used for their isolation and 8 genes were
over-represented in the PDGFR signaling pathway. Other genes over-represented at
the RNA level and validated at the protein level with monoclonal antibodies by FACS
include VCAM1 and CD51 (Integrin αv) (Figure 4-11 A&B).
We then compared the gene expression profiles between the CD105POS and
CD105NEG populations and looked for genes that differed by greater than 2 fold in
either group with a p-value<0.01. This approach generated a relatively short list of
genes that began to delineate potential different biological roles for each population
in vivo. Of interest, gene ontology analysis of genes over-represented in the
CD105POS population suggests this population is more closely involved with blood
vessel development and vasculature stability and would be consistent with at least a
proportion of the cells with this phenotype exhibiting a perivascular location (Table 43 & 4-4). This transcriptome analysis is also consistent the observations from the
immunocytochemistry of sorted LinNEGPDGFRα/βPOS cells and the FACS analysis of
both transgenic mouse lines suggesting that a fraction of the CD105POS cells
express markers of more mature pericyte/mural cells (Figure 4-6). Of additional
interest is the high level of expression of TGFβ receptor type II, which has been
shown to form a complex with endoglin (CD105) in order to bind TGFβ 1 and act as
a proliferation induced signal [127]. This may potentially also be a mechanism to
augment TGFβ availability and its reported negative effects on endothelial cell
proliferation.
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Figure 4-11: Microarray validation at the protein level with monoclonal
antibodies. (A) Gene list and average signal detection of RNA for cell surface
markers identified by microarray analysis. (B) Validation of RNA targets at the
protein level by flow cytometric analysis with monoclonal antibodies.
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The CD105NEG population, however, was enriched for a set of genes involved
in skeletal development and bone mineralization. Some of the genes overrepresented in the CD105NEG population include markers of immature osteogenic
cells such Col1a1, osteonectin (SPARC), alkaline phosphatase 2, as well as
markers of more mature osteoblasts including bone sialoprotein (IBSP), osteocalcin
(BGLAP) and osteopontin (SPP1). Additionally, the CD105NEG population is enriched
in cartilage related genes such Col2a1, cartilage oligomeric matrix protein (COMP)
and chondrocadherin (CHAD) [128 & 129]. These noted differences in transcriptional
profile together with our data demonstrating decreased proliferation in vitro,
decreased bone forming potency in vivo and the lack of secondary CFU-F
generating potential, all point to the CD105NEG population as being enriched in
progenitor cells more committed to the osteogenic and chondrogenic lineages. As
well, the higher expression of osteoblast specific genes for extracellular molecules
suggest that this population is likely located adjacent to the endosteal region and
trabecular bone regions within the marrow cavity providing cells and ECM proteins
for the maintenance of general bone tissue turnover (Table 4-3 & 4-5).
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Table 4-3: Gene Ontology of genes enriched within CD105POS or CD105NEG
populations.
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Symbol

Gene Name

Genband ID

p value

ANGPTL1

Angiopoietin-like 1

NM_028333.2 1.81623E-05 2.958333333

DCN

Decorin

NM_007833.1 0.00604199 2.233201581

ENG

Endoglin (CD105)

NM_007932.1 4.84317E-09 9.784090909

SORT1

Sortilin 1

NM_019972.2 0.007979028 2.016632017

LRP5

Low density lipoprotein receptor protein 5

NM_008513.1 2.30866E-05 3.607929515

MEOX1

Mesenchyme hemeobox 1

NM_010791.3 0.002107609 2.215189873

GPX1

Glutathione peroxidase 1

NM_008160.5 6.90256E-06 2.711608338

CD248

Endosialin

NM_054042.2 8.87381E-05 8.819672131

THY1

Thymus cell antigen 1, theta

NM_009382.3 0.003093214 18.77852349

SMO

Smoothened homolog

NM_176996.3 0.000100612 2.486803519

IGSF10

Immunoglobulin superfamily, member 10

XM_913941.2 4.62296E-07 2.1046875

FBLN1

Fibulin 1

NM_010180.1 3.01266E-07 2.57518797

DLK1

Delta-like 1 homolog

NM_010052.4 0.049367371 6.642857143

TGFBRII

Transforming growth factor, beta receptor II

NM_009371.2 0.007696796 2.461538462

LAMA2

Laminin, alpha 2

NM_008481.2 0.001017185 5.918032787

Table 4-4: Lists of genes over-represented in the CD105POS population.
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Fold Change

Symbol

Gene Name

Genband ID

p value

IBSP

Integrin binding sialoprotein

NM_008318.1

3.07659E-05 2.67

BGLAP1

Bone gamma carboxyglutamate protein 1

NM_007541.2

0.000176856 5.67

BGLAP2

Bone gamma-carboxyglutamate protein 2

NM_001032298.2

0.000891292 6.55

COL1A1

Collagen Type I alpha

NM_007742.2

1.3889E-12 2.83

COL2A1

Collagen Type II alpha

NM_031163.2

0.000281482 5.22

GHR

Growth Hormone receptor

AK053579

5.8483E-05 2.38

FOXC1

Forkhead box C1

NM_008592.2

1.26119E-05 2.69

ACD

Adrenocortical dysplasia

NM_001012638.1

2.80899E-05 2.03

COMP

Cartilage oligomeric matrix protein

NM_016685.1

1.24222E-20 14.13

AKP2

Alkaline phosphatase 2

NM_007431.1

9.41673E-06 2.28

CHAD

Chondroadherin

NM_007689.4

0.005079723 18.05

SPARC

Secreted acidic cysteine rich glycoprotein

NM_009242.3

0.000236805 2.28

CFD

Complement factor D (adipsin)

NM_013459.1

0.00465436 3.42

ITGA10

Integrin, alpha 10

NM_001081053.1

0.002085691 2.31

SPP1

Secreted phosphoprotein 1

NM_009263.1

0.002306057 2.71

GNAQ

Guanine nucleotide binding protein, alpha q

AK085933

1.1452E-05 2.24

Table 4-5: Lists of genes over-represented in the CD105NEG population.

127

Fold Change

4-4: SUMMARY

These studies describe the identification of two phenotypically distinct
clonogenic stromal cell populations, based on the cell surface immuno-phenotype of
LinNEGPDGFRα/βPOSCD105POS and LinNEGPDGFRα/βPOSCD105POS. Interestingly,
both populations contribute independently to CFU-F and stromal cell cultures in
whole bone marrow samples. However, following serial passaging WBM adherent
cultures eventually become homogeneous for CD105 expression. However, when
each subpopulation is isolated by FACS and cultured separately, no interconversion
between the two phenotypes in vitro is observed. Studies designed to rationalize the
discrepancy between these two observations demonstrated that the CD105POS
population as a whole exhibits a greater proliferative ability and thus out-competes
the CD105NEG cells. Additionally, it has been previously reported that endoglin
(CD105) is essential for proliferating endothelial cells. CD105 functions as a TGF-β
co-receptor by forming a complex with TGF-β receptors type I, II and III. This
complex binds TGF-β1 and abrogates the growth inhibitory effects of TGF-β1 [127].
Both populations contain stromal stem/progenitor elements that demonstrate
tri-lineage differentiation capacity (osteogenic, adipogenic and chondrogenic) in vitro
and in vivo as shown by the formation of histologically proven bone, BM adipocytes
and

hematopoiesis-supportive

stroma.

Interestingly,

within

the

LinNEGPDGFRα/βPOSCD105POS fraction, we identified a subpopulation, which coexpresses several markers of mature pericyte/mural cells and is enriched in genes
related to blood vessel development and structure suggesting a perivascular nature
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and function in situ. In contrast, transcriptome analysis of the CD105NEG population
revealed a gene expression profile consistent with cells more committed to the
osteo-chondro lineages suggesting this population represents a source of more
immediate progenitors in vivo.
Together, these data suggest the identification of a stromal stem/progenitor
cell hierarchy previously unrecognized within adult mouse BM. Based on these data,
we propose a speculative model for a stromal stem/progenitor cell hierarchy in vivo
within adult murine BM (Figure 4-12). Although we are not at this time able to
conclusively prove the validity of this model, our functional assays and
transcriptional profiling nevertheless suggest that these two populations are enriched
in progenitor cells with over-lapping and distinct functions in vivo. However, because
only a rare percentage of the CD105POS cells express either NG2 (4.2%) or αSMA
(7.1%), this suggests that the majority of CD105POS cells are not mature perictyes,
which raises an interesting question. Could the CD105POS population contain a
stromal cell hierarchy with a primitive stromal stem cell “MSC” population residing
within the CD105POS fraction, which gives rise to additional subpopulations of cells
expressing CD105 and/or lacking CD105 expression? If so, perhaps a greater
biological difference exist between the CD105POS and CD105NEG stromal cell
fractions in vivo that we are unable to determine with the current protocols.
One potential way to prove the existence of this proposed hierarchy would be
to utilize candidate genes identified in our microarray analysis as a means to identify
those genes with tightly restricted patterns of expression in either the CD105POS or
CD105NEG populations and to utilize the promoters for these genes in lineage tracing
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studies to follow the fate of each population under homeostasis and in injury models
of bone tissue. These types of studies would also prove useful in identifying the
original identity and localization in situ of the cells so often identified in vitro as
CFU-F and MSC.
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Figure 4-12: A speculative model for a stromal cell hierarchy. A rare
subpopulation within the CD105 fraction gives rise to CD105POS and CD105NEG
multi-potent clonogenic progenitors, which generate CFU-F and adherent marrow
cultures. In vivo, the CD105NEG population is located a further distance away from
the vasculature along the endosteum and provides committed osteoprogenitors for
the maintenance of bone specific ECM components. The CD105POS progenitors
primarily give rise to the reticular stromal network, adipocytes and mature pericytes.
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CHAPTER 5:

FUNCTIONAL ASSESSMENT OF AN IN VITRO MODEL OF THE
HEMATOPOIEITC MICROENVIRONMENT
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5-1: PREFACE

In Chapter 5, I evaluate the ability of each primary BM stromal subpopulation,
described and characterized in the previous chapter, to recapitulate the functional
properties of the hematopoietic microenvironment in vitro by determining their
capacity, using co-culture assays, to maintain and/or expand long-term repopulating
mouse HSCs. For these studies, a CD45.1/CD45.2 congenic transplant model was
utilized to investigate the potential of ex vivo co-cultured mouse HSCs to provide
long-term multi-lineage blood repopulation in lethally irradiated host. I began these
studies by first, successfully employing the FACS-based methodology described by
Kiel, et al. [20] to isolate HSCs from adult mouse bone marrow and demonstrated
their potency in the F1 chimeric transplant model used for these studies. By using
this well-validated transplant model along with rigorous long-term primary and
secondary blood reconstitution assays, a quantitative assessment was conducted to
determine the capacity of different stromal cell subpopulations to support the
maintenance and/or numerical expansion of competitive long-term repopulating
HSCs down to the single cell level.
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5-2: INTRODUCTION

Adult stem cells are responsible for the overall tissue demands of the
organism both during homeostasis and during time of stress and this is particularly
true for highly regenerative tissues such as the intestine, skin and bone marrow
[130, 131]. Within the bone marrow of adult mammals, HSCs act through a cellular
hierarchy and give rise to all of the mature cells within the hematopoietic system.
HSCs are functionally characterized by their ability to undergo extensive selfrenewal in vivo for the life of an organism and provide serial long-term reconstitution
of the entire hematopoietic system when transplanted into lethally irradiated mice
providing evidence of extensive differentiation potential [3, 15]. On a daily basis, the
hematopoietic system must be prepared to meet the demands of the body included
during normal homeostasis as well as disease and/or stress induced by infection
and acute blood loss. Consequently, the hematopoietic system is poised to rapidly
respond to these external demands and therefore is tightly controlled by the bone
marrow microenvironment.
The balance between self-renewal (generation of self) and differentiation
(production of daughter cells with progressively less self-renewal potential and more
mature in function) [41] is a highly coordinated and regulated process, governed by
both intrinsic (cell-autonomous) and extrinsic (non-autonomous) mechanisms [7] and
a detailed understanding of these mechanisms stands at the forefront of
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considerable interest in HSC biology for the purposes of regenerative medicine and
gene therapy.
The advances made by identifying and isolating nearly homogeneous
populations of HSCs has yielded significant amounts of information regarding cell
intrinsic regulatory mechanisms controlling stem cell behavior. However because of
many technical challenges in dealing with bone-bone marrow tissue, the role of
regulatory molecules governing cell extrinsic behavior has been much slower to
progress and as a consequence there currently remains a lack of complete
understanding of this process. The persistence of HSCs throughout adult life is
contingent upon the permissive microenvironment in which HSCs reside in vivo,
originally proposed in the niche hypothesis [16]. In the adult mouse, the bone
marrow is the primary site of hematopoiesis during homeostasis and several reports
have documented the role of the bone marrow microenvironment in regulating HSC
behavior as described in Chapter 2 of this dissertation. From these studies, several
key molecules have been discovered which play essential roles in governing HSCs
under normal growth conditions. Additionally, there is convincing evidence that the
hematopoietic microenvironment may also contribute to abnormal conditions such as
aplastic anemia and cancer and these observations have further driven interest in
the microenvironment for the purpose of therapeutic targeting under disease
conditions [132].
One approach taken by many investigators to identify extrinsic regulators of
HSCs has been through the use of mouse genetics. Several mouse models have
been generated and have led to the identification of many genetically necessary cell135

extrinsic factors for maintaining HSCs in vivo [15, 44]. Such molecules include SCF,
Angiopoietin 1, CXCL12 (SCF-1), osteopontin, and Ca2+ ion. However, while the
application of mouse genetics as applied to gain- and loss-of-function studies has
resulted in significant discoveries of these genetically determined factors, there still
remains a paucity of information and limitations as applied to this approach in
identifying the specific cells types responsible for generating these regulatory
molecules in vivo. This disparity can be partially attributed to several distinguishing
complications in working with bone marrow tissue. To name a few, there is currently
a lack of cell surface markers suitable for identifying subpopulations of candidate
niche cells in vivo, few cell specific promoters which could potentially be used to
drive Cre-recombinase in deleting specific molecules in specific subpopulations of
stromal cells and the outstanding difficulty of imaging live animals through thick
cortical bone tissue.
A second approach taken by many investigators has been to apply the longterm bone marrow culture system first reported by Dexter and colleagues [60, 61] as
a means to interrogate the heterogeneous microenvironment in vitro. As reviewed in
the previous chapters, the bone marrow microenvironment is comprised of a diverse
population of hematopoietic macrophage and non-hematopoietic stromal cells.
Together these cell types comprise a complex three-dimensional scaffold upon
which cells of hematopoietic origin migrate and receive various cues governing their
behavior. Interestingly, long-term marrow cultures are largely comprised of adherent
cells, which mimic the hematopoietic microenvironment in vivo and this culture
system has yielded significant discoveries regarding extracellular regulatory
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molecules in addition to the ones identified through a genetic based approach.
However, although diverse in cell types, this current culture system does not allow a
prospective analysis of the exact cells responsible for forming these adherent layers
with HSC supporting behavior. Lastly, as demonstrated by Dexter and others, this
culture system primarily supports the proliferation of hematopoietic progenitors with
a progressive loss in HSC function [61].
Some of the hematopoietic cytokines which have been elucidated by these
combined approaches and well-studied in vitro include Il-3, Il-6, SCF, TPO, Flt3-L, Il11 [133]. Resulting from these discoveries, many labs have attempted to study the
role of these factors, alone or in various combinations, by in vitro based suspension
culture approaches. Although some combinations have been reported to support the
maintenance of HSCs [62], under these suspension culture conditions, HSC function
is often rapidly lost and little ex vivo expansion of functional HSCs is observed.
These studies indicate the need for additional cellular and/or molecular components
more closely representative of the microenvironment in vivo. Since the initial studies
conducted by Dexter and colleagues [61] demonstrating the necessary role of the
adherent bone marrow stroma in maintaining primitive mouse hematopoietic
progenitor cells, a great amount of interest has been placed on identifying the key
cellular components within this heterogeneous layer, which provides the greatest
supportive capacity.
Because long-term marrow cultures are performed in the context of a
heterogeneous mixture of adherent cells, this approach does not lend itself to a
prospective analysis of the cells responsible for providing either positive or negative
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HSC regulatory functions. One popular method employed to overcome this limitation
has been to generate cloned stromal cell lines and test their ability to support
hematopoietic stem and progenitor cells in vitro. And while some success has been
garnered using cell lines derived from fetal tissue, such as the fetal liver line
AFT024, little evidence exists of cells with a similar capacity within the adult BM [63].
This raises the question of whether or not the correct cells responsible for supporting
HSCs in vitro have ever been isolated.
Additional complications arising from these studies include the use of high
concentrations of horse serum and a number of the reported studies use
heterogeneous populations of hematopoietc cells enriched for stem/progenitor cells,
but have not been demonstrated at a signle cell resolution to determine the
proportion of cells that contain true LT-HSC repopulating ability. Taken together, it is
not clear what combined negative effects these external factors may be contributing
to the attrition of functional HSCs and the observed lack of HSC expansion. A key
question still needing to be addressed is the nature and identity of the adult BM
stromal cell(s) responsible for supporting the maintenance or expansion of HSCs
both in vivo and in vitro. However, there has been an emergence of experimental
evidence beginning to point to the stromal stem/progenitor cell as a key cellular
constituent of the vascular niche. Interestingly, several lines of emerging data are
resulting in a [134] unified notion that two stem cells not only occupy the same
microenvironment, but also suggest that one stem/progenitor population, the MSC,
is directly involved in the extrinsic regulation of the other, the HSC. And although,
previous studies indicate the existence of two anatomically distinct niches [15, 44],
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what most of these models leave out are the stromal cell reticulum, which spans the
entire width and length of long bones. It appears for our own studies and those of
others that non-hematopoietic stromal elements may provide the critical link in
defining a unified HSC niche.
In the following chapter, we provide direct and indirect evidence that the dual
properties of stromal stem/progenitor cells (MSC; osteoprogenitors) in generating
bone and bone marrow tissue also coincides with their role as cellular constituents of
the bone marrow microenvironmental ‘niche’. Having previously identified distinct
subpopulations of BMSCs each with stromal stem/progenitor activity in vivo, we also
demonstrate their ability to support the maintenance of HSCs in vitro by co-culture
assays and in vivo transplantation studies. Furthermore, data from our transcriptome
analysis of freshly isolated BMSC populations and analysis of a specific genetic
mouse model suggests a direct role of these populations in establishing and
maintaining the hematopoietic stem cell niche in vivo by governing HSC behavior.
We therefore, hypothesized that the cellular constituents of the vascular niche in vivo
would provide a discovery platform from which to identify cells with HSC
maintenance capabilities in vitro and would additionally provide an experimental tool
from which to identify novel HSC regulatory molecules in future studies.
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5-3: RESULTS

DISTINCT POPULATIONS OF BMSCs EXPRESS HIGH LEVELS HSC
REGULATORY MOLECULES IN VIVO
Having identified perivascular cells that are LinNEGPDGFRα/βPOSCD105POS
and direct osteo-progenitor cells (CD105NEG) each with the capacity to transfer the
hematopoietic microenvironment in vivo using an ectopic transplantation model, we
postulated that at least a portion of the cells within these two populations represent
the cellular elements of the vascular/perivascular HSC niche. This notion was further
supported by our transcriptome analysis of prospectively isolated
LinNEGPDGFRα/βPOSCD105POS and CD105NEG populations. Based on these
microarray studies, both populations were shown to express significant levels of a
number secreted molecules known genetically to be involved in regulating HSCs in
vivo, consistent with their proposed role as niche cells (Table 5-1). Additionally, both
populations have high levels of transcripts for extracellular matrix components and
adhesion molecules (Table 4-1, Chapter 4) that have also been implied as having
established roles in regulating hematopoiesis within the context of the hematopoietic
microenvironment [131, 135].
Furthermore in collaboration with Dr. Sean Morrison’s lab, we have
demonstrated that both stromal cell populations, LinNEGPDGFRα/βPOSCD105POS and
CD105NEG, represent the major cell source for stem cell factor (SCF) in vivo and
their selective depletion leads to a 50% reduction in functional HSCs in the adult BM
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[136, and personal communication]. Taken together, these data demonstrate a role
for the LinNEGPDGFRα/βPOSCD105POS and CD105NEG populations in establishing and
maintaining the vascular/perivascular niche in vivo, unifying the dual role of the
stromal stem/progenitor population as both osteoprogenitors and HSC niche
constituents. Based on these observations, we reasoned that both populations
would recapitulate, in vitro, the supportive microenvironment function of maintaining
HSCs and provide a platform from which to identify additional HSC regulatory
molecules that would permit the ex vivo expansion of functional HSCs.
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Table 5-1: Hematopoietic stem cell regulatory molecules expressed in vivo by
LinNEGPDGFRαβ POSCD105POS and LinNEGPDGFRαβ POSCD105NEG populations.
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ESTABLISHING THE TRANSPLANT MODEL
HSCs have been isolated to near homogeneity using a combination of cell
surface markers referred to as the LSKSLAM immunophenotype (LSKCD48CD150+), based on the lack of expression of mature hematopoietic markers (Lin-),
expression of Sca1 and c-kit (SK), lack of expression of CD48 (CD48-) and
homogeneous expression of CD150 (CD150+) [20]. Although rigorously
demonstrated by other labs, our lab had not previously used this specific
immunophenotype to isolate HSCs so a formal limit dilution analysis of their
repopulating ability was still lacking. Additionally, we used CD45.2 (C57Bl/6)/
CD45.1 (B6.SJL/Ptprc^aPep^3/BoyJ) F1 chimeric mice as a recipient source for
these transplantation studies so it was essential to determine the repopulating ability
of SLAM HSCs in these mice and to determine the reproducibility and reliability of
detection of low numbers of input competitor cells, test cells and support cells for the
analysis of the co-culture studies. Furthermore, this analysis would provide the
foundation for determining the number of input cells to be used in our co-culture
system.
To generate F1 chimeric mice, we crossed C57Bl/6 mice, with the CD45.2
allele (Ly5.2) expressed in all hematopoietic cells, to B6.SJL/Ptprc^aPep^3/BoyJ
mice which express the CD45.1 allele (Ly5.1) in all hematopoietic cells (Figure 5-1).
The resulting F1 progeny contain both CD45.1 and CD45.2 alleles in all
hematopoietic cells representing a double positive population by flow cytometric
analysis with a combination of CD45.2 and CD45.1 monoclonal antibodies
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Figure 5-1: Generation of LT-HSC reconstituting transplantation model. Adult
male CD45.2 (C57Bl/6) mice were mated to adult female CD45.1
(B6.SJL/Ptprc^aPep^3/BoyJ ) mice and the resulting F1 progeny are used as
recipients for all reconstituting transplantation studies.
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Figure 5-2: Schematic of F1 Peripheral Blood analysis in WT and following
lethal irradiation and competitive transplantation. (A) Peripheral blood analysis
of control F1 chimeric mouse using CD45.1 and CD45.2 monoclonal antibodies. (B)
Peripheral blood analysis of an F1 mouse under competitive repopulating assay
conditions. Following lethal irradiation F1 mouse transplanted with 100 HSCs
isolated from CD45.2 mice along with 300,000 whole bone marrow cells isolated
from CD45.1 mice.

145

(Figure 5-2 A). Additionally, this model allows for the monitoring of transplanted
hematopoietic cells in a direct competitive reconstitution assay, whereby donor cells
can be competed against an HSC population of know reconstituting ability and also
allow the determination of reconstitution provided by the recipient (support cells)
(Figure 5-2 B).
To begin these studies, SLAM HSCs (Figure 5-3) were double sorted to
ensure their purity from CD45.2 mice at 8-10 weeks of age and visually confirmed
microscopically in terasaki wells to contain the appropriate number(s) of input cells
(Figure 3-4 A). Next, we transplanted 3, 10, 30 or 100 SLAMHSCs into lethally
irradiated F1 mice, 8-12 weeks of age along with 300,000 whole bone marrow
(WBM) cells isolated from CD45.1 mice at 8-10 weeks of age. Hematopoietic
reconstitution was measured by determining the percentage of donor type (test) cells
in the peripheral blood at 6, 12 and 20 weeks and within the bone marrow at 20
weeks.
In these experiments, mice receiving 3 SLAM HSCs demonstrated on
average a 4.25% chimerism of CD45.2 donor HSCs (Figure 5-4 B) in the peripheral
blood with 25% demonstrating long-term multi-lineage reconstitution. However, all
mice transplanted with 10 (100%), 30 (100%) or 100 (100%) cells demonstrated
multi-lineage reconstitution with 64-90% of the hematopoietic cells being donor
derived out to 20 weeks post-transplant (Figure 5-4 B). Since 10 SLAM HSCs
reproducibly provided significant levels of donor-derived multi-lineage reconstitution
at 20 weeks post-transplant (Figure 5-5 A-C, D & E), we reasoned that 10 input
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Figure 5-3:Gating strategy for the prospective isolation of SLAM HSCs. HSC
sort gates are set to first determine the appropriate scatter profile and to select for
single cells by a doublet exclusion gate. Next, viable cells are gated on to remove
dead cells from the analysis. All viable single cells are the subjected to a
hematopoietic lineage positive gate to remove mature hematopoietic cells and a
stem and progenitor gate is used to enrich for HSC by gating on all c-kit & Sca1
double positive cells. The final gates are set to enrich for a well-validated HSC
population based on lack of expression for CD48 and positive expression of CD150.
Finally the LSKCD48-CD150+ cells are resorted to ensure a pure population for LTHSC transplantations.

147

Figure 5-4: LSKSLAM cells are highly enriched for LT-HSCs. (A) Microscopic
validation and enumeration of cells for transplantation. (B) Percentage of donor
derived CD45.2 cells in peripheral blood at 20 weeks post-transplantation. (C)
Representative FACS plots of peripheral blood analysis at 20 weeks post-transplant
demonstrating high levels of donor derived multi-lineage reconstitution (D) with 10,
30 & 100 freshly isolated HSCs at 20 weeks post-transplantation (n=5 mice per
group).
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Figure 5-5: Donor derived multi-lineage blood reconstitution. Multi-lineage
blood reconstitution was evaluated by flow cytometric analysis and the percentage of
donor derived T cells (A), B cells (B) and myeloid cells (C) for each mouse was
plotted for the 20 week post-transplant time point. Representative FACS plots for
peripheral blood and bone marrow analysis demonstrating donor derived
hematopoietic cells (D) and multi-lineage reconstitution (E) from 10 freshly isolated
CD45.2 HSCs.
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Table 5-2: Global reconstitution of SLAM HSCs cells per input dose.
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SLAM HSCs would be sufficient as the input dose for our initial series of co-culture
studies.
EVALUATION OF LT-HSC SUPPORTING ACTIVITY
We next set out to compare the ability of the CD105POS and CD105NEG
populations to support long-term multi-lineage reconstituting HSCs in vitro by coculture assays. For these experiments, LinNEGPDGFRα/βPOSCD105POS and
LinNEGPDGFRα/βPOSCD105NEG BM stromal stem/progenitor populations were
isolated from F1 chimeric mice and allowed to reach confluence in 48 well plates
coated with fibronectin. Approximately 5-7 days after isolation and plating in normal
growth media, SLAM HSCs were double sorted from B6.SJL/Ptprc^aPep^3/BoyJ
(CD45.1) mice (Figure 5-6 A) and 10 HSCs were visually counted (Figure 5-6 B) and
added to each well containing a confluent layer of BM stromal stem/progenitor cells
(Figure 5-6 C) in Stem Span serum free expansion media supplemented with a
combination of the following cytokines each at 1/10th the optimal concentration: IL-6
(10ng/ml), SCF, TPO and Flt3L (each at 5ng/ml). As a control, 10 HSCs were
added to wells coated with fibronectin, which did not contain any stromal layers in
the presence of the 0.1X concentration of cytokines (Figure 5-6 C, top panel).
Previous studies in our lab had determined that at a 0.1x cytokine concentration
HSCs do not proliferate and most die. Therefore, this concentration would allow us
to examine the direct contribution to HSC survival and expansion provided by the
stromal layers.
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Figure 5-6: Schematic of SLAM HSC isolation and co-cultures. (A)
Representative FACS plots showing the gating strategy to double sort SLAM HSCs.
(B) Microscopic image of a single terasaki well confirming an accurate count of
HSCs. (C & D) Schematic drawing of co-culture conditions and images depicting the
mouse model used as transplant recipients.
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The co-cultures were left undisturbed and maintained at 5%CO2, 5%O2 at
37°C for a total of 10 days. 10 days after the initial seeding of wells with SLAM
HSCs, we observed a significant increase in hematopoiesis in the wells containing
either CD105POS (Figure 5-7, middle panel) or CD105NEG (Figure 5-7, right panel)
stromal layers, however we could not detect any increase in hematopoietic cells in
the control stromal-free wells under these culture conditions (Figure 5-7, left panel).
Following the 10 days in culture, the entire contents of each well was collected with
trypsin and placed into separate tubes on ice in PBS. Additionally, 300,000 WBM
cells from F1 mice were added to each co-culture cell suspension. The entire
contents of each tube was then transplanted into the retro-orbital sinus of lethally
irradiated 8-12 week C57Bl/6-B6.SJL/Ptprc^aPep^3/BoyJ (CD45.1/CD45.2) F1
chimeric mice.
Peripheral blood analysis from two independent experiments was evaluated
for donor-derived reconstitution at 6, 12 and 16-18 weeks. Additionally, bone marrow
was collected at the time of sacrifice and 1 million WBM cells were serially
transplanted into lethally irradiated F1 secondary recipient mice from each
experiment that contained multi-lineage reconstitution in the primary transplant
recipients in order to assess in vivo self-renewal potential. In this experimental
setting, all mice transplanted with the progeny of 10 HSCs from either CD105POS
(100%) or CD105NEG (100%) stromal cell co-cultures demonstrated robust multilineage reconstitution in primary (Figure 5-8) and secondary recipients (Figure 5-9).
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Figure 5-7: Robust hematopoiesis in adult BM stromal-HSC cocultures.
Representative images of robust hematopoietic activity from 10 input HSCs at day
10 of cocultures with CD105POS and CD105NEG adherent stromal layers. HSCs
cultured in suspension without stromal layers do not expand and most undergo rapid
attrition and cell death.
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However, we could not detect any donor-derived reconstitution from
suspension cultures (Figure 5-8 A&B). On average, the progeny of 10 HSCs cocultured with CD105POS BMSC gave rise to 65+23.6% donor derived CD45.1 cells in
the peripheral blood while the progeny of 10 HSCs co-cultured on CD105NEG BMSCs
provided 49.3+19.5% donor derived CD45.1 cells in primary transplant recipients
(Figure 5-8 A&B). Although the CD105NEG population demonstrated slightly lower
levels of blood reconstitution, the difference was not statistically significant.
Successfully reconstituted primary recipients from CD105POS and CD105NEG BMSC
co-cultures were able to reconstitute secondary recipients with 100% efficiency
generating, 56.5+29.4% and 40.15+24.1% donor derived CD45.1, respectively
(Figure 5-9 A&B). Furthermore, transplanted HSCs derived from CD105POS or
CD105NEG co-cultures (10 input HSCs) were able to out-compete the 300,000 WBM
cells (approximately 18 HSCs) demonstrating that both BM stromal cell populations
maintain functional HSCs ex vivo.
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Figure 5-8: Maintenance of transplantable LT-HSCs is dependent on CD105POS
and CD105NEG BMSCs. (A) Long-term multilineage reconstitution from 10 SLAM
HSCs co-cultured on CD105POS and CD105NEG BMSCs. (B) Representative FACS
plots from peripheral blood analysis at 18 weeks pot-transplant.
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Figure 5-9: SLAM HSCs co-cultured on CD105POS and CD105NEG BMSCs
demonstrate robust ability to undergo self-renewal in vivo. (A) Long-term
multilineage reconstitution in secondary recipients provided by 10 SLAM HSCs cocultured on CD105POS and CD105NEG BMSCs. (B) Representative FACS plots from
peripheral blood analysis at 18 weeks pot-transplant.
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PRIMARY CD105POS BMSCs SUPPORT HSC EXPANSION EX VIVO
In order to begin addressing the question of whether or not either population
supported the expansion of HSCs ex vivo, we conducted a series of additional
transplantation experiments using either limiting numbers of the progeny cells
derived from the HSC co-cultures or by initiating the co-cultures with a single SLAM
HSC. We first conducted a preliminary experiment to evaluate the potential
numerical expansion of co-cultured HSCs based on a limit dilution analysis of 10
input HSCs. For this experiment, 10 freshly isolated HSCs from CD45.1 mice were
placed into co-cultures for 10 days under the identical conditions detailed above and
transplantation assays were based on a limiting dilution of the cultured progeny.
Following the 10 day co-culture period, lethally irradiated F1 mice were transplanted
with either the total progeny from 10 input B6.SJL/Ptprc^aPep^3/BoyJ (CD45.1)
HSCs, 1/2 the input progeny (5 cell equivalents), 1/3 the input progeny (3 cell
equivalents) or 1/10th the input progeny (1 cell equivalent). Additionally, freshly
isolated SLAM HSCs were double sorted from C57BL/6 (CD45.2) mice and 10
(CD45.2) HSCs along with 300,000 WBM cells from F1 mice were added to each coculture cell suspension dilution. Based on the design of our transplant model, we
were able to track in vivo the respective multilineage differentiation potential of each
population (Figure 5-2 B) and to determine the ability of cultured HSCs to compete
against prospectively isolated HSCs in vivo.
In this experimental design, the product of 10 HSCs from CD105POS cocultures outcompeted the 10 freshly isolated HSCs by more than 5/1-10/1 ratios
providing on average 74.4% of the total hematopoietic content as compared to 6.3%
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Figure 5-10: Competitive repopulation between co-cultured HSCs and freshly
isolated HSCs. (A) FACS plots demonstrating a competitive advantage of
CD105POS BMSC co-cultured HSCs over freshly isolated HSCs, while CD105NEG
BMSC co-cultured HSCs demonstrate equal potency to freshly isolated HSC in
head-to-head competitive transplant setting. (B) Total blood reconstitution from mice
transplanted with various cell equivalent doses of co-cultured progeny at 6, 12 and
20 weeks post-transplant. (C) 1 SLAM HSC equivalent from CD105POS BMSC coculture demonstrates long-term multi-lineage blood reconstitution.
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blood reconstitution derived from the freshly isolated CD45.2 HSCs (Figure 5-10 A,
left panel). However, blood reconstitution levels were nearly identical between the
progeny of 10 CD105NEG co-cultured HSCs (41.9%) as compared to 10 freshly
isolated HSCs (32.8%) in the same mouse (Figure 5-10 A, right panel). In the mice
transplanted with the product 5, 3 or 1 cell equivalents we did not observe a
significant difference in total blood reconstitution (Figure 5-10 B), however, we did
observe a significant difference in the level of multilineage reconstitution between
the two groups at each of these cell doses. Specifically, with each cell dilution from
CD105NEG co-culture we observed a significant decrease in cells of the myeloid
lineage and at the 1 cell equivalent dose the CD45.1 donor cells were completely of
the lymphoid lineage (Figure 5-10 C) suggesting that as HSCs divide in co-cultures
with CD105NEG BMSCs the cells become biased towards the lymphoid lineage.
However, mice transplanted with each dilution of the progeny from the
CD105POS co-culture all demonstrated multi-lineage engraftment out to 20 weeks
post-transplant including those transplanted at the 1 cell equivalent dose
(Figure 5-10 C). Perhaps more importantly, multiple mice demonstrated long-term
multi-lineage engraftment at 20 weeks at the 1 cell equivalent dose from the
CD105POS co-culture as compared to only 1 mouse surviving from the CD105NEG coculture at 1 cell equivalent dose. Collectively, these data suggest that the 10 input
HSCs (CD45.1) from the CD105POS co-cultures under went expansion ex vivo, while
HSCs from the CD105NEG co-culture did not expand but rather some were
maintained as functional stem cells in culture. Although, mice transplanted with
limiting numbers of CD105POS co-cultured HSCs did provide long-term reconstitution,
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the lower numbers of input co-cultured progeny failed to outcompete the 10 freshly
isolated C57Bl/6 (CD45.2) HSCs (Figure 5-10 C) suggesting that the level of
expansion was not at a 10 cell equivalent dose.
To better address the prospect of HSC expansion, we set up a series of
experiments to ask the question if a single co-cultured HSC could reconstitute
lethally irradiated mice in a competitive transplantation assay. For these studies, a
single double sorted B6.SJL/Ptprc^aPep^3/BoyJ (CD45.1) HSC was placed into
culture wells containing confluent layers of either LinNEGPDGFRa/bPOSCD105POS or
CD105NEG BMSC population (Figure 5-11). Following 10 days of culture, each well
was transplanted into lethally irradiated F1 Chimeric mice that initially contained a
single HSC. As shown in 5-12 A, co-cultures from the CD105POS group contained
more hematopoietic progeny and when transplanted these cultures demonstrated
significantly greater ability to provide long-term multi-lineage blood reconstitution in 7
of 8 mice with an average level of CD45.1 reconstitution of 50.6+26.9% (Figure 5-12
B &C, Figure 5-13 A-C). The CD105NEG co-cultures generated on average
23.3+26.1% donor derived engraftment with only 4 of 8 mice surviving and showing
donor derived reconstitution (Figure 5-12 B & C, Figure 5-13 A-C).
In this same set of transplantation studies, we also transplanted the progeny
of a single co-cultured HSC into 10 mice to assess the level of HSC expansion from
the single initiating HSC. Of note, 5 out of the 10 mice transplanted with the progeny
of a single HSC co-cultured with CD105POS BMSCs demonstrated long-term
observable levels of blood reconstitution (Table 5-3). However, levels of multilineage repopulation were not equally distributed across mice and consisted of a
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larger proportion of lymphoid reconstitution with some mice containing only low
levels of myeloid reconstitution. These data suggest that HSCs can expand at a
clonal level in vitro when cultured on CD105POS BSMCs. In agreement with our
previous transplantation studies, none (0 of 10) of the mice from the single HSC
CD105NEG co-culture showed any level of reconstitution (Table 5-3). Although, these
results indicate a significant difference in the ability of the CD105POS BSMC
population to maintain and expand transplantable HSCs at a clonal level compared
to the CD105NEG population, more work is needed to formally quantitate this
difference at the clonal level in primary and secondary recipients. By transplanting
multiple mice with a variety of cell doses from clonally derived co-cultured HSCs one
could determine by Poisson statistics the level of functional LT-HSC expansion.
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Figure 5-11: Schematic of single HSC co-culture assays. SLAM HSCs were
double sorted as shown previously and microscopically counted. Wells containing a
single HSC were transferred to BMSCs co-cultures for 10 days and transplanted into
a single lethally irradiate mouse or a single well was split into 10 mice.
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Figure 5-12: CD105POS BMSCs support the expansion of single SLAM HSCs in
long-term competitive transplantation assays. (A) Images of co-cultures derived
from a single HSC at the time of transplantation. (B) Donor derived blood
reconstitution at 6 and 16 weeks post-transplant from a single co-cultured HSC. (C)
Representative FACS plots of peripheral blood analysis demonstrating multi-lineage
reconstitution by single co-cultured HSC.
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Figure 5-13: Long-term multi-lineage repopulation derived from clonal HSC cocultures with BMSC subpopulations. Peripheral blood reconstitution from donor
derived T cells (A), B cells (B) and myeloid cells (C). Data represent mean + Std.
Dev. (D) Schematic diagram demonstrating increased ex vivo expansion of clonal
HSCs in CD105POS BMSC co-cultures.
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Table 5-3: Reconstitution by clonally expanded HSC in to multiple mice.
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5-4: SUMMARY

Taken together, these co-culture transplantation studies provide evidence for
different roles in the CD105POS and CD105NEG BMSC populations in vitro. While both
populations demonstrate the ability to support the maintenance of HSCs at a 10 cell
input dose, only the CD105POS population was able to demonstrate any observable
level of expansion of repopulating HSCs. These findings provide insight into
potential different functional roles in vivo as well. It is possible that HSCs migrate
away from the vascular niche and lose contact with the CD105POS perivascular niche
cells, where they either enter into cell cycle and/or begin to differentiate along the
long cellular processes of the intravascular CD105POS/NEG stromal reticulum, in
accord with the model proposed by Nagasawa et al [25]. There is experimental
evidence for this model in regards to B cell development [137]. Additionally, it is
possible that HSCs closely associated with the CD105NEG osteo-progenitor cells
along the endosteal region are exposed to qualitatively different growth factors that
maintain HSCs in a more quiescent/dormant state [29 & 67-71]. Invoking such a
model also implies perhaps a direct role for the involvement of the sinusoidal
endothelial cells not only in governing HSC behavior, but perhaps more importantly
a role in governing the behavior of the perivascular niche cells, which may support
self-renewal divisions of HSCs localized to the vascular niche.
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CHAPTER 6:
DISCUSSION
AND FUTURE DIRECTIONS
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In this dissertation, I have made progress towards addressing two key
outstanding questions in the field of bone marrow stromal cell biology. First, I have
presented experimental evidence of a robust reproducible methodology that
simultaneously yields the non-hematopoietic clonogenic stromal population as well
as the vascular fraction from adult murine bone marrow. This methodology has in
turn enabled studies that have led to the in vivo identification and prospective
isolation of distinct populations of BMSCs that each fulfill the criteria for defining
‘stromal/mesenchymal stem cells’ based on the gold standard assay of in vivo
heterotypic bone formation. Additional data provide evidence in support of the
hypothesis that the two stromal cell subpopulations represent a stromal cell
hierarchy in vivo. Furthermore, these studies have also provided evidence in support
of the existence of a perivascular/reticular niche for HSCs, a transcriptional profile
consistent with the role of these stromal cells as candidate HSC niche cells in vivo
and in addition have resulted in the identification of a subpopulation of BMSCs that
support transplantable HSCs in vitro.
The bone marrow has garnered considerable interest of many investigators
from the perspective of basic science as well as regenerative medicine and stem cell
based therapies. This interest can largely be derived from the observation that the
bone marrow represents a rarely unique organ in that it is the residence of two
widely studied adult stem cell populations, one is of hematopoietic origin
(hematopoietic stem cells) and has been demonstrated at the single cell level to
generate the entire hematopoietic system [20]. The other stem/progenitor population
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is of a non-hematopoietic stromal origin, commonly referred to as stromal or
mesenchymal stem cells (MSC) and by virtue of function as an osteoprogenitor has
the proposed role of contributing bone physiology [120, 134]. The unique feature of
the bone marrow’s system of dual stem cell components, which interact on a
functional level, raises many promising opportunities for discoveries in the regulation
of HSCs and bone biology in both normal and disease conditions [7,91, 132].
HSCs represent one of the most well characterized adult mammalian stem
cell populations studied to date [1] while the canonical properties of MSCs, in
contrast, have proven to be much more elusive. Progress in exploring the identity
and physiological role of MSCs in the mouse model has been considerably
hampered by the paucity of knowledge regarding cell surface markers suitable for
both in situ identification and prospective isolation of these stromal stem/progenitors
[27] and arguably, also by the inadequate methodologies that have been used to
obtain MSC from bone marrow. This is in dramatic contrast to progress in the
identification and purification of murine HSC using monoclonal antibodies to cell
surface markers where it is now routinely possible to isolate HSC at near unity as
demonstrated by complete regeneration of the entire hematopoietic system following
transplantation of a single prospectively isolated HSC [20]. However, the derivation
of MSC from the BM of mice continues to represent a particular challenge to those
investigators who seek to exploit the power of mouse genetic models to answer
questions regarding the basic biology of MSC or who wish to conduct preclinical
studies in the mouse as a means to test newly developed MSC-based cellular
therapies.
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A large focus of this dissertation was centered around addressing one of the
major factors contributing to the difficulty in establishing homogeneous cultures of
murine BM stromal cells, namely the low incidence of CFU-F in the BM which varies
between 0.3 – 2 CFU-F/ million BM cells (C57Bl/6) up to approximately 3 CFU-F per
million (BALB/c) across various mouse strains [97, 102, 109]. In accord with these
data, in the current study C57Bl/6 BM prepared by standard flushing methods used
in a majority of laboratories and assayed under the conditions described in these
previous reports contains 0.22-2.33 CFU-F per million cells. However, when BM
cells were isolated using the alternate protocol described in this dissertation, the
frequency of CFU-F was increased to approximately 380 CFU-F per million
mononuclear cells based on limit dilution analysis.
This dramatic improvement in the incidence and recovery of CFU-F was a
consequence of several methodological improvements, the first and most significant
being the means by which BM cell suspensions were prepared prior to CFU-F
assay. We demonstrate that the generation of plugs of marrow with a preserved
microvasculature followed by sequential enzymatic disaggregation of the plugs,
consistently yielded CFU-F numbers at least 2 orders of magnitude greater than
those obtained by the standard flushing technique. It will be noted that this approach
is somewhat analogous to that used to isolate MSC from adipose tissue in which
enzymatic digestion of the stromal vascular fraction is required to release MSC from
their association with blood vessels [142]. The importance of the means by which
BM is rendered into a single cell suspension on the recovery of CFU-F was also
recognized by Friedenstein and colleagues [109] who reported enhanced CFE when
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BM was prepared by mechanical dissociation followed by trypsin digestion of
remaining clumps.
Also contributing to the improved recovery of CFU-F in presented here is the
establishment of the assays at low oxygen tension. CFU-F cultures initiated at 5%
O2 demonstrated a 30-fold increase in CFE compared to those established under
normoxia, findings in keeping with previous studies [144]. Aside from their
perivascular location, [22, 23, 115] little is currently known about the molecular
composition of the niche occupied by CFU-F in the BM in vivo, but these findings
would suggest that stromal progenitors, like hematopoietic stem cells, [145] occupy
a hypoxic microenvironment. It should also be noted that the high plating efficiency
of CFU-F demonstrated in these studies is occurring in the absence of exogenous
mitogenic growth factors such as FGF2 or feeder cells as shown in previous reports
[97, 108, 109] to be necessary for optimal CFE of CFU-F from mouse BM. Our data
in no way exclude a role for accessory cells and their products in promoting the
growth of CFU-F and it will be of interest to determine if the CFE reported here can
be further improved following addition of feeder cells and/or growth factors and
moreover, to define the requirements of CFU-F isolated using the new methodology
for growth in serum-free conditions.
Growth of the DBM cells at high cell density resulted in adherent cell layers
containing both stromal cells and vascular endothelial cells, in addition to
hematopoietic cells, thereby demonstrating the ability of this new methodology to
facilitate isolation of the BM stromal-vascular fraction. From these primary cultures
we successfully isolated by FACS, vascular endothelial cells and were able to
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serially passage these cells in vitro as a largely homogeneously pure population. To
our knowledge, this represents the first report demonstrating successful isolation
and propagation of vascular endothelial cells from mouse BM and we anticipate this
finding will significantly advance studies of these relatively poorly characterized cells.
In the same primary cultures, LinNEG/PDGFRα/βPOS cells were shown to
comprise approximately 30% of adherent cells and upon FACS, generated cultures
of polygonal fibroblast like cells which expressed a range of cell surface markers
previously ascribed [27, 103, 104, 110] to murine BM-derived MSC, demonstrated
robust multi-lineage differentiation in vitro and gave rise to bone ossicles containing
bone marrow following ectopic transplantation. From the femora and tibiae of 5 mice
prepared using the new methodology, we typically isolate by FACS between 1 – 2
million stromal cells at P0 and up to 20 million by P3 over a 3 week time period. This
compares with less than 1 million cells generated using the standard flush
methodology at P3, which often times are still contaminated with hematopoietic cells.
Such cultures were difficult to passage beyond P3 in contrast to those cultures
initiated from DBM, likely a consequence of senescence due to exhaustion of the
proliferative capacity of the markedly lower numbers of CFU-F recovered in flushed
BM.
Further to these differences in cell generative potential, flow cytometric
analysis of LinNEG/PDGFRα/βPOS cells prepared from flushed and DBM-derived
cultures also revealed phenotypic differences. MSC derived from flushed BM
exhibited high levels of Sca-1 and abundant expression of Thy-1 on the majority of
cells as described previously whereas DBM-derived cells demonstrated 10-fold
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lower levels of Sca-1 and low level Thy-1 on only 25% of the population. In addition,
CD105 demonstrated bimodal expression on DBM MSC with distinct CD105POS and
CD105LOW/- populations in contrast to the flushed BM MSC in which only the
CD105POS population was evident. Although the significance of this observation was
initially

unclear,

it

was

noteworthy

that

in

freshly

prepared

DBM,

the

LinNEG/PDGFRα/βPOS population also exhibits the same bimodal expression of
CD105 (see Figure 3-9). Our initial interpretation of this finding was that while DBM
allows isolation of both subpopulations of BMSCs, BM prepared by the standard
flushing technique may bias toward the CD105POS subpopulation perhaps as a
consequence of their selective survival during BM isolation or preferential outgrowth
in vitro, both of which became a question we sought to address. Further studies to
explore the disparity in cell populations elicited by the two BM cell isolation
methodologies were addressed in Chapter 4 of this Dissertation.
An important advance described in the current studies was the successful
prospective isolation of CFU-F from BM of adult wild-type mice. Previous reports
used either murine fetal bone [123] or were reliant on transgenic mice strains
expressing

specific

reporters

[23,

24].

Initially,

by

focusing

on

the

LinNEG/PDGFRα/βPOS stromal cell population as a whole, we were able to show that
all of the CFU-F activity in both C57Bl/6 and BALB/c mice was derived using this
immunophenotype and the increased frequency of this population in BALB/c mice
correlating with a significant increase in CFU-F incidence in this strain, in agreement
with previous studies [102]. These data highlight the utility of this methodology and
suggest its broad applicability to the isolation and quantitation of stromal progenitors
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across different strains of inbred mice. Finally, in accord with our hypothesis that the
low yield of MSC achieved by flushing of BM reflects the loss of these cells
associated with the marrow vasculature, whole mount staining of BM plugs
demonstrated LinNEG/PDGFRα/βPOS cells both in perivascular locations and as a
network of stromal cells in inter-sinusoidal regions of the BM (see Figures 3-10, 3-11
& 3-12).
The notion that a single stromal stem/progenitor population is responsible for
CFU-F activity within the bone marrow is a widely disseminated concept within the
field of MSC biology. However, in this dissertation we provide direct evidence
challenging this notion. With the development of the novel isolation and imagining
strategies described in this dissertation and the identification of cell surface markers
useful for in situ localization, we choose to further elucidate the physiological
relevance of the bimodal distribution with respect to CD105 expression within
primary adherent cultures as well as within freshly prepared DBM cell suspensions.
To this end, we provided evidence that two phenotypically distinct populations within
the adult murine BM both contribute to CFU-F activity as well as to the initiation of
long-term MSC cultures (Figure 4-1 & 4-2).
Although these two populations contributed to the generation of adherent
stromal cell cultures at clonal and non-clonal plating densities at nearly equal
frequency, the LinNEGPDGFRαβPOSCD105POS population represented a significantly
greater number of total cells in freshly prepared tissue and in whole bone marrow
cultures upon serially passaging. Additionally, the CD105POS population contains a
significantly greater number of CFU-F when prospectively isolated from fresh BM
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tissue. The question then becomes, why? Is there a functional and/or physiological
difference in the activity of these two populations that might explain the difference in
frequency?
To address these questions, we used a series of in vitro and vivo assays
coupled with transcriptional profiling of prospectively isolated subpopulations to
explore differences between the properties of these two stromal cell subpopulations.
With the development of an isolation strategy to prospectively isolate BMSC
subpopulations, we were in a unique position to address fundamental questions in
the MSC field. In particularly, where are MSC located in vivo and what are their
physiological functions. Unfortunately, the large body of data in the MSC field,
especially regarding murine MSC, is based on what amounts to a retrospective
analysis and characterization of ‘MSC’ performed following extensive serial
propagation in vitro [27, 103, 104, 110]. Because, culture conditions are substantially
different from the native in vivo environment, it is likely that these analyses will be
significantly biased as a consequence of studying the properties of stromal
stem/progenitor populations maintained under non-physiological conditions ex vivo.
By defining a composite cell surface immunophenotype that demonstrates fidelity in
vitro (Figure 3-9) and in vivo (Figure 4-1 & 4-2), these studies have provided
evidence that the non-hematopoietic stromal elements in bone marrow are not
entirely representative of the homogeneous populations most often studied and
characterized in long-term cultures.
In addition to the isolation of distinct clonogenic (CFU-F) populations, we
describe the existence of two BMSC populations that contribute independently to the
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generation of ectopic bone complete with BM adipocytes and hematopoieticsupportive stroma defining each population as having with stem/progenitor activity.
Additionally, our transplantation data suggests that there is a difference in both the
potency and kinetics ascribed to heterotopic bone ossicle formation by each of these
populations.

The

stromal

cell

subpopulation

identified

as

the

LinNEGPDGFRα/βPOSCD105POS fraction is able to generate bone-bone marrow tissue
at a faster rate in vivo with fewer cells than that determined within the
LinNEGPDGFRα/βPOSCD105NEG fraction. Additionally we demonstrate that when
recovered from ectopic bone tissue, the LinNEGPDGFRα/βPOSCD105POS fraction also
gives rise to cells identified as CD105LOW/NEG suggesting that CD105NEG cells are a
derivative of LinNEGPDGFRα/βPOSCD105POS cells. Furthermore, we provide evidence
that mature pericytes/mural cells are also a subpopulation of the larger CD105POS
population. Does this data point to a potential model of a stromal stem progenitor
hierarchy?
Evidence in support of this notion was derived from transcriptional profiling of
prospectively

isolated

LinNEGPDGFRα/βPOSCD105POS

and

LinNEGPDGFRα/βPOSCD105NEG populations. Our microarray data demonstrates that
the CD105NEG population contains a list of over-represented genes classically
identified in skeletal development and bone mineral biogenesis, including markers
such as Col1a1, osteonectin and alkaline phosphatase which are thought to be
contained in immature osteogenic populations. The CD105NEG fraction also
expressed genes at the RNA level consistent with cells of a more mature osteoblast
nature, including bone sialoprotein, osteocalcin and osteopontin [22, 121].
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Additionally, the CD105NEG population is also enriched in cartilage related genes
such Col2a1, cartilage oligomeric matrix protein and chondrocadherin (CHAD) [128,
129]. Together, these data suggest that the CD105NEG population represents cells
more committed to the osteogenic and chondrogenic lineages and thus are
positioned further downstream of a stromal stem cell that may also give rise to cells
of more mature pericyte function as well.
Emerging evidence from lineage tracing studies suggest that there are
perivascular cells within adult mouse bone marrow developmentally derived from
two distinct embryological origins, the mesoderm [121] and neural crest [122].
However, these authors do not address whether or not the labeled cells seen in
these models are the same cells routinely used and characterized as MSC from
adult BM tissue. So the question from these studies remains open as to whether or
not adult BM stem/progenitor stromal populations are derived from different
development lineages. Our data suggests that the population often characterized in
the literature as being CD105POS in culture is of the same mesodermally derived
source as the CD105NEG progenitor population. From these findings, we speculate
that

the

CD105POS

population

contains

a

rare

population

of

immature

stem/progenitor cells which gives rise to the cells of a mature pericyte function [125]
as well as cells of the CD105NEG population which serve as more direct
osteoprogenitor cells closely aligned with the endosteal region, growth plate and
potentially bone trabeculae serving as the major reservoir of committed cells
providing bone and cartilage specific ECM proteins potentially contributing to the
overall maintenance of bone tissue turnover.
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Together, these data suggest the identification of a stromal stem/progenitor
cell hierarchy previously proposed [86], yet largely unrecognized within the BM
stromal cell field. Based on these data, we propose a speculative model describing a
stromal stem/progenitor cell hierarchy in vivo within adult murine BM (Figure 4-12).
Although we are not at this time able to conclusively validate this model, our
functional assays and transcriptional profiling data suggest that these two
populations are enriched in clonogenic progenitor cells with over-lapping and distinct
functions in vivo. Additionally, similar evidence has been provided in fetal derived
bone tissue [123]. It will be of great interest to the field of MSC biology as well as
studies focused on defining the formation and maintenance of HSC niches to
determine how these two populations interact to form distinct microenvironments
with perhaps different biological functions in vivo.
One potential way to provide additional experimental evidence for this
proposed hierarchy would be to utilize genes identified in our microarray studies that
are differentially expressed and conduct extensive lineage tracing studies to follow
the fate of each population under homeostasis in the embryo and the adult as well
as in injury models of bone tissue in the adult. If this model is correct and the
CD105NEG population represents a more committed progenitor downstream of the
CD105POS stem/progenitor population, then we would not expect to see any
contribution to the CD105POS population from labeled cells derived from transgenic
mice expressing Cre-recombinase under the control of promoters identified from our
microarray studies of over-represented genes in the CD105NEG population similar to
studies conducted using the Col1A1 promoter described by Maes et al. [121]. It
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would be of great interest to use this strategy to identify the source of cells that not
only form the bone marrow stromal tissue during development, but more importantly
those cells that serve as the endogenous source of adult stromal stem cells. Are
they truly perivascular cells as suggested and if so do they have their own unique
microenvironment contributing to self-renewal? These types of studies would also
prove useful in identifying the original identity and localization in situ of the cells so
often identified in vitro as CFU-F and MSC.
Within the adult BM, functional HSC activity is maintained through interactions
with stem cell niches. Two current models suggest the existence of distinct HSC
niches, one proposed niche involves osteoblast cells closely associated with the
internal surface of the bone, referred to as the endosteal niche [18, 19, 29, & 69].
While subsequent studies have identified a vascular/perivascular niche comprised of
sinusoidal endothelial cells and perivascular stromal cells [20-26]. And with the use
of mouse genetics several key regulatory molecules have been identified as being
necessary to maintain functional HSCs in vivo [14-15 &44]. However, it is currently
not known which cell types are the primary sources responsible for generating these
regulatory molecules in vivo. Currently, it is the interest of many laboratories to
dissect specific regulatory networks, which govern HSC behavior in an extrinsic
mechanism and to identify the primary cells contributing to this direct extrinsic
regulation. In Chapter 5 of this dissertation, we begin to elucidate to identity of
stromal cell subpopulations, which are the major source of genetically necessary
HSC regulatory molecules and contribute to the maintenance and expansion of
HSCs ex vivo.
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To this end, I describe a well-validated transplantation model to tract in vivo
the blood reconstitution derived from co-cultured HSCs, which are directly competed
against freshly isolated HSCs. From these studies, we demonstrate that two BMSC
populations are able to maintain functional HSCs in culture; however only the
CD105POS BMSC population demonstrated the ability to significantly outcompete
freshly isolated HSCs. Furthermore, I developed a co-culture system that allows for
the study of the expansion of functional clonally derived HSCs. In these
experiments, CD105POS co-cultured HSCs (100%) demonstrated a significant
increase in donor derived multi-lineage reconstitution, while only 4 of 8 mice (50%)
from CD105NEG -single HSC co-cultures demonstrated blood reconstitution,
suggesting a more limited expansion of functional stem cells. Taken together, these
results demonstrate that the PDGFRαβCD105POS stromal cell subpopulation is
distinguished by a unique capacity to support the expansion of long-term
reconstituting HSCs in vitro.
In this experimental setting, it is possible to determine the fate of
individual stem cells in a well-validated transplant model. Furthermore, single cell
qPCR and microarray analysis could be applied to gain a better understanding of the
extrinsic regulation governing these differences in HSC behavior. When done in
combination with lineage tracing studies of the candidate niche cells, it could, for the
first time, be a method to identify different microenvironments in vivo with different
functional roles. Although, the evidence provided in this dissertation makes
significant advances to the field of MCS and HCS niche biology, there is still much
more work that needs to be done in order to better address each of these
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outstanding questions that have largely been unanswerable. With the development
of this novel approach to the isolate phenotypically defined BMSC subpopulations
comprising the stromal tissue of mouse BM, it is to be hoped that these studies will
ultimately contribute to a greater understanding of the role of stromal cell
subpopulations in regulation of hematopoiesis, and will complement efforts currently
underway in other laboratories based on the use of transgenic mouse models.
The isolation and characterization distinct clonogenic BMSC populations with
different functional roles in vitro and in vivo are the major findings of this dissertation.
Taken together, we propose a model (Figure 6-1) in which a stromal cell hierarchy
lays the foundation for creating distinct microenvironments in vivo with different
functional roles in regulating HSCs. We propose that the CD105POS BMSC
population contains a subpopulation of perivascular stromal stem cells closely
associated with the abluminal surface of sinusoidal vessels comprising the vascular
niche. Within this microenvironment, HSCs are able to undergo self-renewal to
maintain the stem cell pool and contribute progenitor cells for the daily requirement
of mature effector cells continuously released into the blood stream. Additionally, the
CD105POS population generates mature pericyte cells associated with the smaller
vessels and generates cells comprising the intersinusoidal reticular network.
Whereas, in support of previous publications [29, 67-71] the CD105NEG osteoprogenitor cells associated with the endosteal region contributes to the regulation of
quiescence/dormant HSCs as well as the differentiation of lymphoid progenitor cells
generating mature B-cells [137]. In support of these proposed roles, our functional
data and microarray analysis points to both populations as being cells comprising
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the CXCL-12-GFP (CAR) cells [24, 25, 137] and those identified using Nestin-GFP
[23] and SCF-GFP [136] mouse models.
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Figure 6-1:Schematic of the Bone Marrow Microenvironment. Proposed model
for a stromal cell hierarchy providing stromal progenitor cells responsible for
generating both perivascular and endosteal niche cellular consitutents in vivo.

187

CHAPTER 7:
MATERIALS AND METHODS
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MATERIALS AND METHODS

Animals
8-12 week old C57BL/6, B6.SJL/Ptprc^aPep^3/BoyJ, BALB/c and NOD-SCID mice
originally purchased from Jackson Laboratories and breed in our animal facility were
used as the source of bone marrow tissue and transplant recipient animals.
Additional mice used as a source of BM cells include; transgenic mice harboring the
NG2-DsRed transgenic mice (Tg(Cspg4-Ds Red.T1)1Akikj) were purchased from
Jackson Laboratories and αSMA-RFP mice were a generous gift from Dr. Frank
Marini at MD Anderson Cancer Center and UBC-GFP mice originally purchased
from Jackson Laboratories were a generous gift from Dr. Mikhail Kolonin at the
University of Texas at Houston. For competitive transplantation assays, C57BL/6
and B6.SJL/Ptprc^aPep^3/BoyJ mice were crossed to generate F1 chimeras which
were used as transplant recipients. Animals were caged under standard conditions
and fed a laboratory diet and acidified water ad libitum. Care and use of the
laboratory animals was according to animal protocols/guidelines established by the
University of Texas Health Science Center at Houston Animal Welfare Committee.
Isolation of Murine Bone Marrow cells
Mice were sacrificed by CO2 asphyxiation and cervical dislocation, femora and tibiae
were excised, cleaned of attached muscle tissue and stored on ice in harvest
medium (PBS supplemented with 2% v/v FBS). To prepare BM cells by flushing, a
23-gauge needle (BD Bioscience) was inserted into the growth plate of femora or
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tibiae from which the epiphyses had been removed at the metaphysis below the
marrow cavity and the bone marrow removed by flushing in 5 mls of PFE (PBS
supplemented with 2% FCS and 2mM EDTA). The resulting suspension was then
triturated several times to break up clumps, drawn through a 20-gauge needle and
filtered through a 70µm cell strainer (BD Bioscience).
To isolate BM plugs, the ends of the tibiae and femora were removed as above and
a 1ml syringe fitted with 23-gauge needle (BD Bioscience) containing ice-cold PFE
was inserted into the growth plate and the BM plug gently expelled from the cut ends
of the bones in 1 ml of PFE. BM plugs were transferred to 15 ml conical tubes
(Falcon) containing a mixture of Collagenase Type I (3mg/mL; Worthington,
Lakewood NJ) and Dispase (neutral protease, grade II; 4mg/mL; Roche) in PBS and
incubated for 15 minutes at 37°C. Following a brief vortex for 10-20 sec on low
setting, undigested BM was allowed to settle and BM cells in suspension transferred
to a new tube containing 10mls of PFE and placed on ice. This fraction is referred to
as fraction 1. To the undigested BM tissue remaining after the first incubation was
added additional Collagenase/Dispase solution and the process repeated an
additional two times yielding fractions 2 and 3, respectively. Each fraction was then
either filtered separately through 70µm cell strainer (BD Bioscience) or the three
fractions were pooled prior to filtration (referred to throughout text as DBM). The
cells were washed twice by centrifugation in PFE prior to plating under various
conditions, as described below.
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CFU-F Assays
For assay of clonogenic fibroblast colony-forming cells (CFU-F), single cell
suspensions of BM cells prepared by the standard flushing methodology or DBM
were plated in triplicate over a range of plating densities in 6-well plates (BD
Bioscience) in 2mls of complete growth medium comprising alpha-MEM (Invitrogen,
Life Technologies, Carlsbad, CA) supplemented with 20% (v/v) lot-selected fetal
bovine serum (Hyclone, Thermo Scientific, Rockford, IL), sodium pyruvate (1mM/ml,
MP Biomedicals), gluta-MAX (2mM/ml), penicillin (100U/ml) and streptomycin
(100µg/ml) (all from Gibco, Life Technologies). Cultures were incubated at 37°C in a
humidified incubator at 5% CO2 and 5% O2 for 72 hours washed with medium and
re-fed with complete growth medium for an additional 11 days. On day 14, wells
were briefly rinsed with PBS and then stained with 0.1% Toluidine blue in 4%
formalin (both from Sigma, St. Louis, MO) to allow enumeration of colonies. Only
colonies containing >50 stromal cells were scored. Additionally for CFU-F assays
from prospectively isolated BMSCs, clusters containing 10-50 cells were scored.
Establishment and Characterization of Primary cultures of DBM (P0 culture)
DBM from digestions 1 – 3 was also plated at non-clonal densities (1 x106/ cm2) to
allow growth both of stromal cells and of vascular endothelial cells. Cells were plated
on dishes or chamber slides (LabTek, Nunc, Rochester, NY) coated with fibronectin
(Sigma) at 5µg/cm2 in either alpha-MEM supplemented with 20% FBS or in EGM2MV (Lonza, Switzerland). Cultures were placed in a 37°C humidified incubator at 5%
CO2 and 5% O2, washed at 72 hours and maintained under these conditions with
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media changes every 3 days until attaining confluence and were designated P0
cultures.
Characterization of the Cellular Composition of P0 cultures
A.) In-situ staining:

P0 cultures established in chamber slides slides were placed

on ice for 30 minutes and washed x3 in ice-cold basal αMEM (Gibco). Cultures were
first incubated with purified rat mAbs, washed and revealed with donkey anti-rat Cy3
(1:500) (Jackson ImmunoResearch, West Grove, PA). Following washing, Fc block
was added for 20 minutes prior to the addition of flurochrome conjugated rat mAb
(see table S1) for 30 minutes on ice. Following mAb staining, cells were fixed in 4%
PFA (Electron Microscopy Sciences, Hatfield, PA) for 15 minutes at room
temperature, washed 3 times in PBS and then coverslipped in Prolong Gold
containing DAPI (Molecular Probes). Imaging was performed on an inverted
fluorescence microscope (Olympus BX51) and captured with an Olympus DP71
camera.
B.) Flow cytometric analysis: P0 cultures or cells at subsequent passages were
detached at day 7 of culture by addition of 0.05% trypsin-EDTA (Gibco) washed in
PFE and filtered through a 40µm cell strainer to obtain a single cell suspension.
Cells were resuspended in 100µl of PFE and blocked in Fc block for 20 minutes on
ice, followed by staining with flurochrome conjugated or isotype control antibodies on
ice for 20 minutes. Prior to analysis, cells were resuspended in PFE containing 0.6
µg/ml DAPI (Invitrogen) and either analyzed on an LSR II (BD Bioscience) or
subjected to FACS using a FACS Aria II (BD Bioscience, San Jose, CA) fitted with a
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100µm nozzle and Blue Diode 488, HeNe 633 and UV 355 lasers to isolate stromal
cells and/or vascular endothelial cells. For complete list of antibodies used for FACS,
see table S1.
Prospective isolation of CFU-F from fresh BM
BM cells freshly prepared from DBM plugs as described above were labeled with the
biotinylated hematopoietic lineage antibody cocktail (Table S1) on ice for 20
minutes, washed, filtered and then incubated with sheep anti-rat Dynal beads
(Invitrogen) according to manufactures instructions. Following removal of bead
bound lineage positive cells, the unbound fraction was incubated in Fc block for 20
minutes on ice and stained with monoclonal antibodies as described above.
Marrow Stromal Cell Differentiation Assays
(A.) in vitro: Purified bone marrow stromal cells isolated by FACS were expanded
in culture in aMEM-20% FBS to passage 3 at which time cultures were used for in
vitro differentiation assays as described elsewhere [102, 104, 138]

Briefly, for

osteogenic differentiation, cells were plated at a density of 4.2x103 cells/cm2 in
αMEM supplemented with 20% FBS, 10-8 M dexamethasone, 5mM inorganic
phosphate and 100uM ascorbate-2 phosphate (ASC-2P) (all from Sigma)

and

cultures for 14 days prior to Von Kossa and alkaline phosphatase staining (Vector
Blue Alkaline Phosphatase substrate Kit; Vector Labs). For adipogenic differentiation
cells were plated at a density of 2.1x104 cells/cm2 in αMEM supplemented with 20%
FBS until the cells reached confluence at which time the medium was changed to
DMEM supplemented with 10% FBS, 10% horse serum, 10-8 dexamethasone, 500
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µM IBMX and 60 µM indomethacin and cultured for 21 days and adipose
differentiation was evaluated following oil red O staining.
Chondrogenic differentiation was carried out according to previously established
protocols [102, 139]. Briefly, 250,000 BM stromal cells were pelleted and cultured in
chondrogenic serum-free media (Lonza) supplemented with 10ng/ml TGF-β3 (R&D
Systems, Minneapolis, MN) in 15ml falcon conical tubes for 21 days. Pellet cultures
were fixed overnight in Zn fixative (Shandon/Thermo, Waltham MA) at 4°C and
processed for standard embedding in paraffin wax according to standard
procedures. Morphological assessment of 5 µm sections was assessed by means of
standard H&E staining and sulfated polysaccharides were revealed following
staining with Toluidine Blue (0.1% w/v; Sigma) and with Alcian Blue 8GX (Sigma)
followed by brief counterstaining using fast nuclear red (Vector Laboratories)
according to standard procedures. Immunohistological staining for collagen type II
was performed by incubating pellet sections with antibody 2B1.5 (Thermo-Scientific)
or isotype control antibody followed by immunoperoxidase staining using the mouse
ABC kit (Vector Laboratories) as previously described [140].

(B.) in vivo: To determine their capacity to form bone in vivo, LinnegPDGFRα/βpos
cells at P3 were collected by brief trypsinization and 1.5x10^6 cells were
resuspended in 50µl αMEM-20% growth media, loaded onto Gel-foam sponges
(Baxter, Deerfield, IL) and covered in a fibrin clot (Sigma) at 37°C. Scaffolds were
then subcutaneously transplanted into 2-3 month old NOD-SCID mice as described
[141]. At 12 weeks, mice were sacrificed, scaffolds were recovered, fixed overnight
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in 10% buffered formalin at 40C and decalcified for 1 week in 10% EDTA, embedded
in paraffin and stained with H&E or Masson’s Trichrome according to standard
procedures. Additional scaffolds were not decalcified and embedded in methyl
methacrylate resin (Lawrence Bone Disease Program of Texas Bone Core, MD
Anderson Cancer Center, Houston, TX) and sections stained using the von Kossa
reaction and with Goldner’s Trichrome.
Whole mount immunofluoroesence staining of bone marrow plugs
Intact bone marrow plugs prepared as above were fixed in freshly prepared 2%
paraformaldehyde for 10 minutes at RT and then washed thrice in DPBS for 15
minutes. Using a scalpel, each plug was cut in two and each half transferred to a
single well of a 96-well round bottom plate (BD Bioscience) for antibody staining. BM
plugs were first incubated overnight at 4°C in blocking buffer comprising DPBS with
3% BSA (Sigma), 2% FCS, 2% horse serum and 2% normal donkey serum (Jackson
ImmnoResearch). BM plugs were then incubated overnight with gentle rocking at
4°C with purified anti-PDGFRα and anti-PDGFRβ antibodies or isotype controls. BM
plugs were then washed throughout the following day at 4°C and incubated
overnight with donkey anti-rat Cy3 diluted 1:500 in blocking buffer. Next, the
samples were washed throughout the day in DBPS supplemented with 2% normal
rat serum (Jackson Immunoresearch) and then incubated overnight with MECA32Alexa 488 and VE-Cadherin-Alexa 488 or with rat IgG1 and IgG2a-Alexa 488 isotype
controls. After washing, the BM plugs were counterstained with DRAQ5 (1:1000;
Biostatus Limited) for 30 minutes at RT, transferred onto cover slips and surrounded
by several layers of 120µm SecureSeal imaging spacers (Grace Biolabs, Bend,
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Oregon) to provide a depth of approximately 300-500µm and then immersed in
prolong gold anti-fade mounting medium (Molecular Probes). After applying a
coverslip, specimens were inverted and allowed to cure overnight in the dark at RT
prior to confocal imaging.
Characterization of vascular endothelial cells
Purified LinnegCD105brightPDGFRα/βneg cells were cultured on fibronectin coated wells
in EGM2-MV. At passage 3, cells were plated into (LabTek,) slides coated with
fibronectin and cultures were analyzed for the presence of endothelial markers by in
situ staining described above. Additionally, cells were plated at 70% confluence and
the following day incubated with 10µg/ml DiI-Ac-LDL (Biomedical Technologies,
Stoughton, MA) for 4 hours at 37°C. Cultures were washes x3 in PBS and imaged
on an inverted microscope for the presence of Ac-LDL uptake.
Isolation of Hematopoietic stem cells
Bone marrow was rigorously flushed with a 25-gauge needle and 5mls of ice cold
PBS-2% FBS, 2mM EDTA and filtered through 40 micron cell strainer (BD
Bioscience). Cell suspensions were subjected to ammonium chloride potassium (BD
Bioscience) for lysis of red blood cells, Fc blocked and stained with antibodies to
mature hematopoietic lineage cells (LIN-), c-Kit, Sca1, CD150, CD48 (all from
Biolegend).

LSKCD48-CD150+ HSCs were double sorted on a FACS Aria (BD

Bioscience).
Co-culture and Long-term competitive reconstitution assay
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Fractionated stromal cell populations were plated in fibronectin coated 48 well plates
at 5,000-10,000 cells/well in complete growth media until reaching confluence. At
which time, LSKCD48-CD150+ HSCs were double sorted from 8-10 week old
B6.SJL/Ptprc^aPep^3/BoyJ and resuspended at 10 cells/µl in Stem Span serum free
expansion media (Stem Cell Technologies). To validate accurate cell numbers, 1µl
of HSC cell suspension was added to a single micro-well in a terasaki plate and the
entire well was imaged and counted. Wells containing 10 cells were then transferred
to a single well of established stromal layers in 500µl of Stem Span supplemented
with Flt3L (10ng/ml), IL-6 (2ng/ml), Kit-ligand (10ng/ml) and TPO (5ng/ml).
Suspension cultures without stromal layers were used as controls. Cultures were
placed at 5%CO2, 5%O2 37°C for 10 days. Following 10 day co-culture period, entire
content of a single well was collected, resuspended in 100ml of PBS with a radio
protective dose of 300,000 WBM cells from 8 week old F1 mice and 10 freshly
prepared LSKCD48-CD150+ HSCs from C57BL/6 mice. The entire cell suspension
was drawn into a 1ml insulin syringe and injected into the retro-orbital venous sinus
of 8-12 week old F1 recipient mice that received 2 doses of 550 rad whole body
radiation with 2 hours of rest between each dose. Mice were maintained on normal
diets with acidified water at libitum. Peripheral blood was obtained at 6, 12 and 18
weeks in EDTA coated micro-tubes (BD Bioscience) and bone marrow was collected
at 16-20 weeks depending on the experiment. Samples were subjected to
ammonium chloride potassium (BD Bioscience) for lysis of red blood cells, Fc
blocked and stained with antibodies to CD45.1, CD45.2, B220, Mac-1, CD3 and Gr1
(all from Biolegend). Following mAb staining cells were washed, filtered and
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resuspended in PFE contain 0.6mg/ml of DAPI and analyzed on a LSRII.
Additionally, 1x10^6 WBM cells collected at 18-20 weeks were transplanted in
lethally irradiated F1 secondary recipients and analyzed as described above.
Illumina Gene expression Analysis
All analyses were performed using GenomeStudio software (Illumina, Inc.) by The
Microarray Core Lab, University of Texas Medical School at Houston. Bone marrow
samples prepared as described above were sorted from 8 week old BALB/c mice
into four groups (Hematopoietic Lineage positive cells,
LinNEGPDGFRα/βNEGCD105BRIGHT, LinNEGPDGFRα/βPOSCD105POS and
LinNEGPDGFRα/βPOSCD105LOW/-) for a total of three independent experiments and
total RNA was isolated using RNeasy RNA isolation kit (Qiagen). Each experimental
sample was kept separate to represent 3 independent biological replicates. Total
RNA amplification and microarray hybridization was performed as follows. We used
300 nanograms of total RNA for all amplifications. Amplification of purified total RNA
samples was done according to the manufactors recommendations using the
Illumina TotalPrep RNA Amplification Kit (Ambion, Cat# IL1791). Briefly, first strand
cDNA synthesis was performed with RNA, T7 oligo(dT) primers and reverse
transcriptase mix and incubated for 2 hours at 42 ºC. Additionally, second strand
cDNA synthesis was performed by first preparing a master mix containing RNase H
and DNA polymerase. The RNase H and DNA polymerase master mix was
immediately added following the completion of the first strand reverse transcription
reaction mix and was incubated for 2 hours at 16 ºC. cDNA filter cartridges (part of
the amplification kit) were used to remove RNA, primers, enzymes and salts that
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would inhibit in vitro transcription. The synthesis of biotinylated cRNA was performed
by in vitro amplification for a 14-hour amplification step in the presence of a dNTP
mix containing biotin-dUTP and T7 RNA polymerase. Following amplification, the
concentration of purified cRNA was determined by a NanoDrop ND-1000
Spectrophotometer (NanoDrop Technologies, DE). Microarray hybridization on the
Illumina Sentrix Beadchip Array Mouse WG-6.v2 arrays was performed as follows.
1.5 micrograms of amplified cRNA product was loaded onto the Illumina Mouse WG6.v2 arrays and hybridization was performed for 17 hours at 58ºC in an Illumina
Hybridization Oven (Illumina, Cat# 198361). Immediately following hybridization, the
chips were washed and the detection of biotin-labeled cRNA on the arrays was done
by incubation with straptavidin-Cy3. Next, Illumina bead arrays were allowed to dry
and subsequently scanned with the Illumina BeadArray Reader (Illumina, CA). All
sata analysis was performed with the GenomeStudio software (Illumina, CA).
Additionally, GenomeStudio and Ingenuity Pathway Analysis (Ingenuity Systems,
Inc.) softwares were used for clustering and pathway analysis, respectively.

Quality control and pre-processing
Raw signals of all the build-in controls were checked as quality control for the
performance of the arrays. Sample-independent controls were used to check:
a. Hybridization (control molecules at low, medium and high concentrations);
b. Signal generation (background, noise, biotin labeling and hybridization at high and
low stringency).
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Housekeeping genes were used as sample-dependent controls. Background was
subtracted and arrays were normalized using quantile. The reproducibility of
biological or technical replicates was checked through comparisons among
individual samples. Outliers were removed if necessary. The remaining samples
were grouped and the average signal intensities of samples within the group were
used for differential expression analysis.
Statistical Analysis
Statistical analysis was performed with SigmaStat version 3.5 with significance being
assigned to p < 0.05.
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Table 7-1: List of Antibodies
Antibody
CD31-FITC
MECA32-Alexa 488
VE-Cadherin-Alexa
488
VEGFR2-purified
PDGFRb purified
PDGFRb-APC
PDGFRa-purified
PDGFRa-APC
CD105-purified
CD105-PECy7

Clone
MEC 13.3
MECA32

Company
BD Bioscience
Biolegend

Dilution
1/100
1/100

BV13
Avas 12a1
APB5
APB5
APA5
APA5
MJ7/18
MJ7/18

eBioscience
BD Bioscience
Biolegend
Biolegend
eBioscience
eBioscience
Biolegend
Biolegend

1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100

Hematopoietic
Lineage Cocktail
CD45-Biotin
CD11b-Biotin
Gr1-Biotin
F4/80-Biotin
CD3-Biotin
B220-Biotin
CD19-Biotin
Ter119-Biotin
CD45-APCCy7
CD11b-APCCy7
F4/80-APCCy7
CD3-APCCy7
Gr1-APCCy7
B220-APCCy7
CD19-APCCy7
Ter119-APCCy7
CD16/32

30-F11
M1/70
RB6-8C5
BM8
17A2
RA3-6B2
6D5
Ter1119
30-F11
M1/70
BM8
17A2
RB6-8C5
RA3-6B2
6D5
Ter119
93

Biolegend
Biolegend
Biolegend
Biolegend
Biolegend
Biolegend
Biolegend
BD Bioscience
Biolegend
Biolegend
Biolegend
Biolegend
Biolegend
Biolegend
Biolegend
BD Bioscience
eBioscience

1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100
1/100

Rb Poly
Goat poly
Rb poly

BD Bioscience
Gentex
Millipore
Jackson ImmunoResearch
Invitrogen
eBioscience

1/100
1/100
1/100
1/500
1/500
1/100

Polyclonal Abs
eNOS
GFP
NG2
Donkey anti-rat Cy3
Steptavidin-594
Streptavidin-ACPCy7
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